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SUMMARY 
Viomycin y ie lds upon complete acid hydrolysis L-ser ine , L-a ,B-
diaminopropionic acid , L-B-lysine (L-3,6-diaminohexanoic a c i d ) , carbon 
dioxide , ammonia, and a strongly basic amino acid named viomycidine 
(2,4,6-tr iaza-3-iminobicyclo[3.2.1]octane-7-carboxylic a c i d ) . The pur­
poses of this research were twofold: f i r s t , to continue the invest iga­
tions into the biosynthetic pathways leading to viomycin by studying 
several suspected b io log i ca l precursors of the amino acids and the other 
components in viomycin; second, to further invest igate the chemistry of 
the intact viomycin molecule. 
Samples of radioact ively labeled viomycin were produced by the 
14 
addition of C-labeled compounds suspected of being precursors of one 
or more of the amino acid residues in viomycin to the growth medium of 
Streptomyces griseus var . purpurea. These samples of viomycin were then 
hydrolyzed, and the hydrolysis components were separated by ion-exchange 
chromatography. The a c t i v i t i e s of the hydrolysis components were deter­
mined, and certain of the hydrolysis components that contained s i g n i f i ­
cant a c t i v i t y were degraded chemically in order to obtain data concern­
ing the label ing patterns of those components. 
14 14 14 ZJL-Arginine-amidine- C, ££-orni thine-l- C, DL-arginine-1- C, 
14 14 14 ££-arginine-5- C, L-a,B-diaminopropionic-U- C acid , L-6- lys ine- C 
( label ing pattern undetermined), and L-viomycidine- l i + C ( label ing pattern 
undetermined) were investigated as possible precursors for viomycin b i o -
14 14 
synthesis. I t was found that the arginine-amidine- C, arginine-1- C, 
ix 
14 . . . . 
and arginine-5- C were incorporated d i rec t ly into viomycidine with no 
14 
scrambling of the labeling pattern. The ornithine-1- C was found to 
be incorporated into viomycidine to a large extent, but i t would appear 
that some scrambling of the labeling pattern occurred. 
14 
£>-Glucose-U- C was used as a precursor in order to produce a 
14 . . . 
source of C-labeled a,3-diaminopropionic acid, 3 - l y s m e , and viomy-
14 
c idine . The a,3-diaminopropionic-U- C acid was used as a precursor 
for viomycin biosynthesis. I t was found that only the a,3-diaminopro-
pionic acid residue of this viomycin sample was labeled and thus, a, 3-
diaminopropionic acid is not a precursor for the other amino acids. 
Similar results were found for the viomycin produced from the 
14 
3 - lys ine- C ( label ing pattern undetermined). Only the 3-lysine from 
this viomycin was labeled, showing that 3- lysine i s not a precursor for 
the other amino acids. 
14 
The viomycidine- C ( label ing pattern undetermined) was not 
incorporated to a s ignif icant extent into any of the amino acid residues 
o f v i o m y c i n . T h i s w a s f u r t h e r e v i d e n c e t h a t v i o m y c i d i n e d o e s n o t o c c u r 
per se in the viomycin molecule, but rather is a product of the acid 
hydrolysis of viomycin. 
15 15 
Lysine- N, serine- N, and 3,3-dideuterioserine were also 
studied as precursors for viomycin biosynthesis. By use of low resolu­
t ion mass spectrometry, i t was found that both nitrogen atoms of lysine 
were incorporated into 3- lysine without prior conversion to free 
ammonia. Serine was also found to contain nitrogen from the lysine 
15 
precursor; the a,3-diaminopropionic acid was found to contain N at 
X 
both the a- and the 3-positions, suggesting that a,3-diaminopropionic 
acid is produced by amination of a serine residue involving a second 
serine molecule as the nitrogen donor. 
15 
From the serine- N precursor, the nitrogen of serine and both 
nitrogen atoms of a ,3-diaminopropionic acid were found to be labeled. 
Only the 3-nitrogen atom of 3-lysine was found to contain 1 5 N - l a b e l i n g . 
These results are in agreement with those of the previous experiment. 
3,3-Dideuterioserine was used as a precursor in viomycin b i o ­
synthesis. Although the mass spectral data were of low precis ion, 
serine and diaminopropionic acid both appeared to retain the two deu­
terium atoms at the C-3 posi t ion, suggesting that the proposal of 
aldehyde formation at C-3 of serine prior to amination i s incorrect . 
I t was found that viomycin was ca t a ly t i ca l ly hydrogenated in 50 
per cent aqueous acet ic acid using a 10 per cent platinum on carbon 
catalyst . Sephadex chromatography of the perhydro product revealed 
this material to be 93 per cent homogeneous. Hydrolysis of perhydro-
v i o m y c i n , f o l l o w e d b y i o n e x c h a n g e chromatography o f t h e hydrolysate, 
showed L-ser ine , £>£-alanine, ammonium chlor ide, L-a,3-diaminopropionic 
acid , L-3-lysine, capreomycidine [a-(2-iminohexahydro-4-pyrimidyl)gly-
c i n e ] , and carbon dioxide as the major components. The serine to 
alanine ra t io was found to be 2 :1 , indicating that alanine i s not pro­
duced from serine by hydrogenolysis of the C-3 hydroxy1 group. The 
pre-viomycidine unit in viomycin was converted into capreomycidine 
during the hydrogenation process. 
xi 
The perhydroviomycin was found to possess no uv chromophore, 
but bioassay revealed that the perhydroviomycin was approximately 30 
per cent as active as commercial viomycin. 
1 
CHAPTER I 
INTRODUCTION 
The Chemistry of Viomycin 
Viomycin is a broad spectrum ant ib io t ic that was isolated in 
1950 simultaneously by Charles P f i ze r and Company"*" and Parke, Davis and 
2 
Company from cultures of Streptomyces pumoeus and Streptomyaes 
ftoridae. While early studies indicated that viomycin was part icularly 
e f f e c t i v e against Mycobacterium tuberculosislater c l i n i c a l studies 
revealed that kidney damage, vestibular dysfunction, e l ec t ro ly t e im-
3 
balance, and hypersensi t ivi ty resulted from extended use. In spi te of 
these rather serious toxic reactions, viomycin is s t i l l used c l i n i c a l l y 
in cases where the tuberculosis microorganism has become resistant to 
streptomycin. 
Analysis of the crys ta l l ine sul fa te , hydrochloride, p icra te , 
and Reineckate salts of viomycin indicated an empirical formula of 
3 M-C H „ J 0 for the free base. ' The sulfate sal t has a spec i f i c 
-Lo o l - o o t) o 
2 
rotation of -39.8° in water and melts at 252° with decomposition. A 
molecular weight of 772 was indicated for the sulfate sa l t from dia­
phragm-cell diffusion studies. This, together with other analyt ical 
data and chemical evidence, suggested a molecular formula of 
C25H44N12°11 " 3 / 2 H 2 S 0 4 ( m o 1 W t 8 3 6 ) ' 5 Summation of a l l known 
hydrolysis fragments gave a molecular formula of c2o
H36Ni207 * 3 / / 2 H2S°M-
g 
(mol wt 707.73). An average of s ix separate analyses of viomycin 
2 
sulfate gave the following per cent composition: C, 35.71; H, 5.83; 
N, 21.19; S, 5.51; C/N r a t i o , 1.69. 
Viomycin is a strong base and has pK values of 8.3, 10.3, and 
a 
12.2 in water. The absence of a pK value lower than 8.3 indicates 
a 
that viomycin contains no free carboxyl group. 5 Van Slyke primary 
amino nitrogen determinations indicated that 1.22 primary amino 
groups in viomycin react in 2.5 min, 1.9 8 groups react in 15 min, and 
2.16 groups react in one hour (based on an assumed molecular weight of 
7 
836). Viomycin gave pos i t ive Sakaguchi and ninhydrin tes t s , but nega-
1 2 7 
t i ve Benedict 's , Fehl ing 's , and maltol t es t s . 9 9 These results sug­
gested the presence of guanidino and amino groups. The fact that v i o -
mycin gave a pos i t ive biuret test together with i t s resistance to mild 
acid hydrolysis indicated that viomycin had a peptidic function. On 
the basis of color tests and the fai lure of viomycin to react with 
periodic acid, the presence of a carbohydrate grouping appeared 
unlikely. 
THE ULTRAVIOLET SPECTRUM OF VIOMYCIN CONSISTS OF ONE STRONG 
absorption, the position and intensi ty of which are dependent on the 
pH of the solution. This absorption appears at 26 8 nm ( E , 23,300) in 
0.1 N hydrochloric acid, at 26 8.5 nm ( e , 22,900) in neutral solution 
and at 282.5 nm ( e , 14,600) in 0.1 N sodium hydroxide. Determination of 
the u l t r av io le t spectra in solutions of pH 10, 11, 12, 13, and 14 indi­
cated two isosbestic points at 2 35 and 281 nm, suggesting that one dis-
5 8 
sociating group was involved with the chromophore. 5 IT was also shown 
that the group involved had a pK value of 12.4, which indicated that 
3 
the guanidino group present in viomycin was involved in the u l t rav io le t 
chromophore. When viomycin was heated in 0.1 N hydrochloric acid at 
100°, the u l t rav io le t absorption gradually decreased and disappeared 
ent i re ly af ter six hours. A lyophi l ized sample of this solution showed 
an u l t rav io le t absorption, however. 
The nmr spectrum of viomycin sulfate in deuterium oxide showed 
absorptions at t 1.93 ( s ) , 5.7-6.4, 6.5-7.6, and 8.0-8.4 in the ra t io 
7 
1:7.4:6.8:6.5, corresponding to the nonexchangeable protons. The 
infrared spectrum of viomycin sulfate as a potassium bromide p e l l e t 
showed very broad absorptions of an indis t inct nature, and no useful 
information has been derived from i t . 
Hydrolysis of viomycin sulfate using 1 N hydrochloric acid at 
37° for 11 days released no amino acids, but the b io log i ca l ac t iv i ty 
was reduced by 75 per cent. Vigorous acid hydrolysis using 6 N hydro­
chloric acid at 100° for 20 hr destroyed the u l t rav io le t chromophore 
4 . 
completely and ammo acids were released. Carbon dioxide , ammonia, 
a n d u r e a w e r e i d e n t i f i e d i n t h e h y d r o l y s i s m i x t u r e . F o u r o t h e r m a j o r 
products, a l l ninhydrin pos i t i ve , were isolated from the hydrolysis 
+ 4 
mixture by using cation exchange chromatography with Zeo Rex (H ) . 
The four ninhydrin pos i t ive products were shown to be L-serine (1_), 
L-a,$-diaminopropionic acid (_2), L-$-lysine (L-3,6-diaminohexanoic acid) 
(_3), and a mixture of guanidino compounds in the ra t io 2:1:1:1. 
L-serine was iden t i f i ed by opt ical rota t ion, analysis, preparation of 
the /l/-2,4-dinitrophenyl de r iva t ive , and by the ident i ty of the infrared 
absorption spectrum with that of authentic L-ser ine . 
4 
+ J 2 
H , N - C - H H 0 N - C - H 
2
 I T 
C H 2 N H 3 
+ 
C H 2 O H C H 2 C H 2 C H 2 N H 3 
Z 3 
L-a,3-Diaminopropionic acid was iden t i f i ed as the monohydrochloride 
sa l t by analysis, van Slyke amino nitrogen determination, and ninhydrin 
carbon dioxide determination. The L-configuration was indicated for 
a,3-diaminopropionic acid on the basis of i t s opt ical rotation and the 
5 
opt ical rotation of the N'-dibenzoyl der iva t ive . Analyses of the 
crys ta l l ine hydrochloride, sulfate , p icra te , and p-hydroxyazobenzene-
p-sulfonate salts of L-3-lysine showed that this compound was ident ical 
with the isomer of lysine previously isolated from streptol in and strep-
tothr icin hydrolysates, which was shown to be ident ical with synthetic 
4- 9 
L-3,6-diaminohexanoic acid. ' 
The mixture of guanidino compounds was found to have one major 
component that was isolated in crys ta l l ine form and named viomyci-
d i n e . ^ 9 ^ A single crystal X-ray diffract ion analysis of viomycidine 
hydrobromide revealed that 2,4-,6-triaza-3-iminobicyclo[3. 2 . l ]oc tane-
7-carboxylic acid (_J+) is the correct structure for viomycidine. 9 9 
One of the minor guanidino components is c losely related to 
14 
viomycidine, and has been named isoviomycidine. This compound gave 
pos i t ive ninhydrin and Weber t es t s , and was found to be very similar in 
chemical properties to viomycidine. I t was bel ieved to be an isomer of 
5 
viomycidine. Isoviomycidine and viomycidine were separated by chroma-
14 + tography of a mixture of C-labeled compounds over a long Dowex-50(H ) 
ion exchange column; isoviomycidine was found to be s l i gh t ly less basic 
than viomycidine. The isoviomycidine fractions were then pooled and 
again chromatographed over the Dowex-50(H+) column. The purity obtained 
by this method was determined by l iquid s c in t i l l a t i on counting of the 
14 
C content of each fraction from the column. This purif ied material 
was converted to both the stoichiometric hydrochloride and hydrobromide 
14 
sa l t s , but neither sal t could be c rys t a l l i zed . The nmr spectrum of 
the purif ied material showed absorptions at x 4 .29-4.75(mult iple t ) , 
5 .60(mul t ip le t ) , and 7.05-8.33(complex mul t ip le t s ) , and was quite dif-
g 
ferent in appearance from the spectrum of viomycidine. No structure 
has yet been derived for isoviomycidine. 
One other guanidino compound was isolated from the acid hydroly­
sate of viomycin and was named v ioc id ic acid (C H N 0 •2HBr•2H 0 ) . 
Viocidic acid was subjected to a single crystal X-ray dif f ract ion 
analysis, which revealed the structure to be 2,5,8,10-tetraaza-9-
6 
iminotricyclo[5 . 3 . 1 . 0^' "'""'"]undecane-6-carboxylic acid (J5_). ' " ^ 
Basic hydrolysis of viomycin with 0.5 N lithium hydroxide or 
0.43 N barium hydroxide at 95° for three days yielded carbon dioxide, 
ammonia, and a number of amino acids. These amino acids were ident i ­
f ied by two-dimensional paper chromatography as 3-lysine, serine, 
5 
a,3-diaminopropionic acid, and alanine. Since alanine was not found 
in the acid hydrolysate of viomycin, the basic hydrolysate was subjected 
to preparative paper chromatography, and a quantity of the alanine was 
16 
isolated and pos i t ive ly iden t i f i ed as Z?L-alanine. The presence of 
alanine in the basic hydrolysis of viomycin and i t s absence from the 
acid hydrolysate was attributed to the attack of base on serine to give 
alanine. I t has been shown that treatment of serine under the same con­
ditions used for the basic hydrolysis of viomycin yie lded a mixture of 
serine and alanine. 
17 18 
Par t ia l acid hydrolysis of viomycin gives four peptides. ' 
Peptide A showed posi t ive ninhydrin and Sakaguchi reactions, pK values 
of 9.9 and 11.2, and gave u l t r av io l e t absorptions similar to viomycin, 
X 275 nm ( e , 5100) at pH 1 and X 29 5 nm ( e , 3600) at pH 10. 
max r max c 
7 
Hydrolysis of Peptide A with 12 N hydrochloric acid gave a,6-diamino­
propionic acid and viomycidine in a 1:1 molar r a t i o . Hydrolysis of the 
2,4-dinitrophenyl derivat ive of Peptide A gave bis-2,4-dinitrophenyl-
18 
a,3-diaminopropionic acid. Peptide B gave equimolar amounts of B-
lysine and serine on complete hydrolysis , and 2,4-dinitrophenylation 
of Peptide B, followed by hydrolysis , gave mono-e-2,4-dinitrophenyl-
17 
8-lysine and #-2,4-dinitrophenylserine. Peptides C and D were only 
isolated from hydrolysis of viomycin with 0.1 N lithium hydroxide in 
low y i e l d . Peptide C was reported to give equimolar amounts of 8-
lysine and viomycidine, and Peptide D gave equimolar amounts of 8-
17 
lys ine , viomycidine, and serine upon complete hydrolysis . 
19 
Kitagawa and coworkers also isolated a series of peptides 
through par t ia l hydrolysis of viomycin. Peptide A was separable into 
three substances, each of which had a peptide sequence of 8- lysylsery l -
diaminopropionylviomycidylserine, where no amino group of a,8-diamino-
propionic acid was f ree . Peptide B was found to be 3-lysylseryldiamino-
p r o p i o n y l ( f r e e 3 - N H ^ ) v i o m y c i d y l s e r i n e , a n d P e p t i d e C w a s s e r y l d i a m i n o -
propionyKfree 3-NH^)viomycidine. From these data and the fact that 
Peptide A gave urea upon mild acid hydrolysis , they suggested that 
the amino acid sequence of viomycin was 3-lysylseryldiaminopropionyl-
(no free NH 2)viomycidylserylurea. 
Oxidation of viomycin by treatment with aqueous potassium per­
manganate, bromine-water, or ozone (hydrogen peroxide workup) destroyed 
the u l t rav io le t chromophore, but no difference was noted between the 
composition of the acid hydrolysate of the oxidation product and the 
8 
c o m p o s i t i o n o f t h e u s u a l v i o m y c i n a c i d h y d r o l y s a t e . 5 J o h n s o n a n d c o ­
w o r k e r s , h o w e v e r , h a v e r e p o r t e d t h a t o x i d a t i o n o f v i o m y c i n w i t h p o t a s ­
s i u m p e r m a n g a n a t e u n d e r u n d e f i n e d c o n d i t i o n s l e d t o f o r m y l u r e a a n d 
o x a l i c a c i d . 
An i n t e r e s t i n g a m b i g u i t y h a s a r i s e n d u r i n g t h e c h e m i c a l s t u d i e s 
on v i o m y c i n . M i c r o o r g a n i s m s t h a t p r o d u c e a n t i b i o t i c s a r e k n o w n t o 
u n d e r g o m u t a t i o n s a n d t o p r o d u c e d i f f e r e n t c o m p o u n d s t h a n t h e o r i g i n a l 
a n t i b i o t i c . A s t r a i n o f S. griseus t h a t w a s known t o p r o d u c e v i o m y c i n 
10 t o 15 y e a r s a g o w a s u s e d r e c e n t l y i n an a t t e m p t t o p r e p a r e v i o m y c i n 
21 
f o r b i o s y n t h e t i c s t u d i e s . N o v i o m y c i n w a s p r o d u c e d b y t h i s m i c r o ­
o r g a n i s m ; i n s t e a d , an a n t i b i o t i c w a s p r o d u c e d t h a t h a d an a b s o r p t i o n 
i n t h e u l t r a v i o l e t s p e c t r u m a t 267 nm i n b o t h a c i d a n d a l k a l i n e s o l u t i o n . 
A n o t h e r s t r a i n o f S. griseus w a s o b t a i n e d f r o m C h a r l e s P f i z e r a n d 
C o m p a n y , w h i c h p r o d u c e s a l l o f t h e p r e s e n t l y a v a i l a b l e c o m m e r c i a l v i o ­
m y c i n . T h i s s t r a i n p r o d u c e d a m a t e r i a l t h a t w a s i d e n t i c a l t o c o m m e r c i a l 
v i o m y c i n . 
14 
When l a b e l e d v i o m y c i n - C w a s p r o d u c e d b y t h i s s t r a i n f r o m t h e 
14 6 
p r e c u r s o r g l u c o s e - U - C , n o u r e a w a s f o u n d i n t h e a c i d h y d r o l y s a t e . 
E v e n a t r a c e o f u r e a w o u l d h a v e b e e n d e t e c t e d , s i n c e t h e u r e a p r e c u r s o r 
i n t h e v i o m y c i n m o l e c u l e w o u l d b e e x p e c t e d t o b e l a b e l e d t o a d e t e c t ­
a b l e e x t e n t . A l l o f t h e o t h e r h y d r o l y s i s p r o d u c t s w e r e s i g n i f i c a n t l y 
l a b e l e d . 
B e g i n n i n g w i t h a new b a t c h o f c o m m e r c i a l v i o m y c i n s u l f a t e r e ­
c e i v e d a b o u t L 9 6 5 , n o u r e a h a s b e e n f o u n d i n a c i d h y d r o l y s a t e s f r o m a n y 
s a m p l e s o f c o m m e r c i a l v i o m y c i n s u l f a t e r e c e i v e d s i n c e t h a t t i m e . U r e a 
9 
was reported as a component of viomycin when i t was f i r s t discovered, 
in early work in this laboratory, and in present work in other labora­
to r i e s . I t is evident that the previous work on viomycin has been done 
on urea-containing "old viomycin" and that the present-day commercial 
viomycin is a "new viomycin" that does not contain a urea residue. No 
other differences in behavior have been noted between "new" and "old" 
13 19 20 
viomycin. Several recent l i te ra ture sources 5 5 report finding 
urea under many different degradative conditions; i t is therefore e v i ­
dent that these workers are s t i l l using the "old viomycin" for their 
studies on viomycin. 
Several structures have been proposed for viomycin, each of which 
is incorrect in l i gh t of the currently accepted data about viomycin. In 
1965, Dyer and coworkers proposed structure 6_ as the structure of v i o ­
mycin."'""'" Kitagawa and coworkers reported the amino acid sequence is as 
19 
is shown in structure _7. Polish workers have suggested yet another 
structure (j3), which does not seem to f i t a large part of the exist ing 
22 
d a t a a v a i l a b l e o n v i o m y c i n . P e r h a p s t h e b e s t s t r u c t u r e f o r v i o m y c i n 
presented so far was proposed by Johnson and his coworkers and is shown 
13 
as structure 9_. 
None of these structures can apply to "new viomycin," since they 
a l l contain a urea residue. Structure 6_ is no longer considered va l id 
due to the fact that i t has been found that the viomycidine residue 
obtained from the acid hydrolysate does not exist as such in the intact 
molecule. Structure 7 was not proposed as a complete structure, but 
only as an amino acid sequence. Structure 8_has no u l t r av io le t 
10 
11 
9 
chromophore and i t is not readi ly apparent how viomycidine could arise 
under the conditions of acid hydrolysis . Although structure 9 contains 
a urea residue, most of the other data on viomycin is consistent with 
this structure, at least for "old viomycin." Simple removal of the 
0 
carbamoyl group (-CNH ) would result in a vinylamine system, which is 
known to be hydrolyzed very rapidly in aqueous solution. For this rea­
son, "new viomycin" apparently d i f fe rs from structure 9 by more than 
just the urea residue. 
The Biosynthetic Studies of Viomycin 
Although l i t t l e direct information is available concerning the 
biosynthesis of the intact viomycin molecule, some information is ava i l ­
able on the biosynthesis of the various hydrolysis products of viomycin. 
12 
Since L-serine is one of the common amino acids, i t should be 
available to the organism producing viomycin e i ther from the growth 
23 
medium or by well-known biosynthetic pathways and could be incorporated 
intact into the viomycin molecule. 
a,f3-Diaminopropionic acid and several of i t s derivatives have 
been isolated from natural sources. Albizzine (a-amino-3-ureidopropi-
24 
onic acid, 10) has been isolated from several species of Uimosaoeae^ 
N H 2 N H 2 
iO II 
and 3-#-oxalyl-a,3-diaminopropionic acid (11) has been isolated from 
25 
Lathyvus sativus. L-a,3-Diaminopropionic acid has been isolated in 
2 6 
high concentration from seeds of Viaia baicalensis and also from the 
27 
hydrolysate of the an t ib io t ic edeine. £-a,3-Diaminopropionic acid 
has been found in the digest ive f lu id of the f i f th instar of the larvae 
2 8 
of Bombyx movi. 
The biosynthesis of a lbizzine has been studied in Albizzi-a 
29 14 14 14 lopavetha by Reinbothe. Glycine-1- C, g lyc ine-2- C, ser ine-1- C, 
14 
and serine-3- C were incorporated into albizzine to a s igni f icant 
14 14 
extent. Formaldehyde- C and glyoxylate-U- C were incorporated to 
14 
some extent, probably via serine. Uric acid-2- C was incorporated 
14 14 14 
s l i g h t l y , but carbon dioxide- C, formic acid- C, urea- C, u r i c i l -
13 
14 14 2- C, and arginine-amidine- C gave only neg l ig ib le incorporation. 
Reinbothe suggested the pathway in Equation 1 for the biosynthesis o f 
29 
a,3-diaminopropionic acid. 
0 
H O " ^ 2 — H ^ ^ r ^ 2 — ^ \ ^ 2 ( l ) 
N H 2 N H 2 N H 2 
In studies done in these laborator ies , 3,3-dideuterioserine was 
incorporated into viomycin. Preliminary low resolution mass spectrom­
etry indicated that the a,3-diaminopropionic acid that was found in the 
14 
acid hydrolysate had two deuterium atoms. This would indicate that 
serine is aminated d i rec t ly by displacement. This evidence does not, 
however, necessarily exclude that the oxidation process is not also 
operative as a possible pathway from serine to a,3-diaminopropionic 
acid. 
L-3-Lysine (3,6-diaminohexanoic acid) has been derived by acid 
hydrolysis from a number of ant ibiot ics other than viomycin, including 
30 . 3 1 32 . 33 
s t reptol in AB, s t reptothr ic in , roseothricin, and geomycin. 
Studies of L-lysine fermentation by an unidentified species of Clostrid­
ium revealed that L-3-lysine accumulated by deletion of the cofactors 
(nicotinamide-adenine dinucleotide and adenosine-5'-diphosphate) required 
34 
for lysine fermentation. I t was also found that 3-lysine i s formed 
from lysine by a readi ly revers ible reaction, that i t i s fermented more 
14 
rapidly than lysine when the suitable cofactors are added to the culture 
medium, and that the addition of lysine does not markedly inhibit 8-
lysine fermentation. I t was concluded that 3-lysine l i e s on or very 
close to the path of lysine fermentation to ammonia and acet ic and 
butyric acids. I t was found that a-ketoglutarate and coenzyme A were 
34 
required cofactors in the conversion of lysine to 3-lysine. In a 
l a te r series of experiments using Clostridium sticklandii, i t was shown 
that the fermentation of lysine to acet ic acid, butyric acid, and 
ammonia involves two successive amino group migrations, f i r s t from the 
a to the 3 posit ion to form 3-lysine, then from the e to the y posit ion 
35 
to give 3,5-diaminohexanoic acid. I t was found that a cobamide enzyme 
was required for the second conversion, but not the f i r s t , which appar-
3 6 
ently requires pyridoxal phosphate instead. In addition, i t was shown 
that both the migration of the a-amino group to the 3-position, and the 
migration of the e-amino group to the y-posit ion does not involve ex­
change with free ammonia nitrogen. These data exclude an a,8-unsaturated 
i n t e r m e d i a t e f o r m e d b y e l i m i n a t i o n of a m m o n i a , f o l l o w e d by readdition of 
ammonia in the 3-position. Also excluded would be any intermediate 
transfer of the amino group to a keto group (transamination) that would 
lead to exchange of the amino group with free ammonia. I t was suggested 
that the reaction mechanism might involve the intermediate formation of 
an azir idine r ing, but no evidence exis ts e i ther to support or eliminate 
36 
this p o s s i b i l i t y . 
The biosynthesis of the viomycidine fragment is not quite so 
clearcut. The structure of viomycidine ( 4 ) has only recently been 
15 
determined. ^ ' " ^ ' " ^ The available data indicate that viomycidine does 
not exis t per se in the viomycin molecule, but exists as a precursor 
that gives viomycidine upon acid hydrolysis. Due to the uncertainty of 
the structure of the viomycidine precursor, very l i t t l e direct informa­
tion is available on the biosynthesis of this precursor. 
Recent studies in these laboratories u t i l i z i n g spec i f i c a l l y 
labeled arginine precursors and one labeled ornithine precursor have 
demonstrated that these amino acids are incorporated into viomycin to a 
large extent, and that the rad ioac t iv i ty appears almost exclusively in 
14 . . 
viomycidine and the related guanidino compounds. I t is not surprising 
that this is true, since arginine ( 1 2 ) , Johnson's proposed viomycidine 
20 
precursor (13_), viomycidine (4_), and the related capreomycidine 
13 3 7 
(14) ' are very similar in structure, as shown in Equations 2 and 3. 
I t is also interesting to note that the viomycidine precursor (13_) can 
20 
be converted into capreomycidine (14_) by hydrogenation of viomycin. 
Pass and coworkers have investigated the or ig in of the guanidino 
3 8 39 
g r o u p in v i o m y c i n . ' T h e y s u g g e s t e d t h a t two t y p e s o f e n z y m e systems 
could be possible for the introduction of the guanidino group into v i o ­
mycin: 1) an arginase system responsible for catabolic breakdown of 
arginine to supply ureido and amidino groups, and 2) the X-amidinotrans-
ferase system that was shown by Walker to be operating in streptomycin 
40 
biosynthesis. I t was found that although arginase ac t i v i t y was high 
when viomycin production was high, spec i f i c inhibi t ion of the arginase 
resulted in only s l igh t reduction in viomycin production, thus ruling 
out the poss ib i l i t y that the enzyme arginase is responsible for the 
39 
introduction of the amidino group into viomycin. 
16 
The fai lure of the arginase system strongly suggested that an 
X-amidinotransferase system was operating in viomycin hiosynthesis, and 
3 8 
this was found to be the case. A strain of Streptomyoes that produced 
viomycin and one that was def ic ient in the X-amidinotransferase system 
(and did not produce viomycin) were compared in a series of experiments. 
Both strains were found to produce the same amount of guanidino com­
pounds, but the composition was d i f fe ren t . Arginine concentration was 
found to remain constant in the producing s train, but increased sharply 
17 
with time in the nonproducing s t rain. Serine was found to be incor­
porated at the same rate in both strains, suggesting that incorporation 
of serine precedes that of the guanidino component. 
The ac t iv i ty of the X-amidinotransferase system was found to be 
highest in the periods of intensive an t ib io t ic production. Inhibitors 
such as canavanine (an antimetabolite of a rg in ine ) , inorganic phosphate, 
and oxygen shortage were found to inhibi t both the X-amidinotransferase 
system and viomycin production. In addition, arginine was found to be 
the best source of the amidino groups; L-a-amino-3-guanidinopropionic 
acid, L-a-amino-y-guanidinobutyric acid, and creatine were less e f f e c ­
t i v e . Cyclic guanidine structures, such as creatinine, were t o t a l l y 
ine f fec t ive as amidino group sources. The facts that the def ic ient 
strain did not produce viomycin and that arginine accumulated in the 
def ic ient strain suggested that an X-amidinotransferase system was in 
operation in viomycin biosynthesis and that arginine was involved in 
some way. 
Walker has recently shown that the biosynthesis, of the guanidine 
constituent of streptomycin, s t rept id ine , from inosamine involves trans-
amidination of the phosphorylated intermediate with arginine as an 
amidine donor. This step was be l ieved to be followed by dephosphoryla-
40 . . 
t ion with a nonspecific phosphatase. A similar mechanism may be 
operative in viomycin biosynthesis. This, of course, does not rule out 
direct incorporation of arginine into viomycin as was indicated in pre-
14 
vious work m this laboratory. 
In order to study the biosynthesis of viomycin and of the unusual 
18 
amino acid fragments of viomycin in these laborator ies , viomycin was 
14 
produced in the presence of C-labeled compounds suspected of being 
14 
precursors of one or more of the fragments of viomycin. The C-labeled 
viomycin was then hydrolyzed using 6 N hydrochloric acid. The hydroly­
sate was then separated into individual components by use of a 2.4 cm x 
450 cm column containing approximately 1650 ml of Dowex 50-WX8(H+) ion 
exchange resin. Complete separation of the hydrolysis components was 
achieved when the column was eluted with a concentration gradient of 
hydrochloric acid. The individual fractions col lec ted from this column 
were then analyzed for rad ioac t iv i ty by the l iqu id s c in t i l l a t i on tech­
nique. Those hydrolysis components that were found to contain s i g n i f i ­
cant rad ioac t iv i ty were degraded further in order to determine the 
g 
complete labeling patterns. 
Several different reactions were used to degrade the hydrolysis 
components to determine label ing patterns. For serine and diaminopro­
pionic acid two separate reactions were used. Periodate oxidation f o l ­
lowed by formation, co l l ec t ion , and counting of the dimedone der ivat ive 
of the formaldehyde produced yielded the ac t iv i ty present in the C-3 
posi t ion. Reaction with ninhydrin reagent by the method of van Slyke, 
41 
et at., oxidized the carboxyl carbon ( C - l ) to carbon dioxide, which 
could then be trapped and counted to obtain the ac t i v i t y at C - l . The 
ac t i v i t y at C-2 was determined by difference. The 3-lysine samples were 
degraded by use of the Barbier-Wieland degradation. The methyl ester of 
N3N'-diphthalyl-3-lysine was prepared by a modification of the method of 
g 
van Tamelen. The methyl ester of NsN'-diphthalyl-3-lysine was reacted 
19 
with phenylmagnesium bromide, and the resulting te r t i a ry alcohol was 
dehydrated in bo i l ing acet ic anhydride. Ozonolysis of the result ing 
o l e f i n , followed by an oxidative workup, gave very low yie lds of N^N'-
diphthalylornithine and benzophenone. Ornithine was obtained by removal 
of the phthalyl protecting groups using hydrazine. The ornithine was 
then reacted with ninhydrin reagent, and the carbon dioxide that was 
produced was trapped in a Hyamine hydroxide solution. The ac t iv i ty at 
C-2 was determined by counting the carbon dioxide; the a c t i v i t y at C-l 
was determined by counting the benzophenone. A c t i v i t i e s of positions 
C-3 through C-6 were determined by counting the ornithine and subtract­
ing the carbon dioxide count. 
Biosynthetic studies on 14 different labeled precursors have been 
14 
completed in these laborator ies . Floyd investigated glucose-U- C, DL-
ser ine-3- l i + C, £>L-serine-l- l i +C , DL- lys ine -2 - 1 4 C, Z?L-glutamic-3,4- l l +C 
14 14 . 14 
acid, DL-glutamic-5- C acid, DL-arginine-5- C, and £>L-aspartic-4- C 
6 14 14 
acid. Rice studied sodium acetate-2- C, g lyc ine-1- C, sodium 
14 14 14 
a c e t a t e - 1 - C , s o d i u m b i c a r b o n a t e - C , s o d i u m f o r m a t e - C , a n d DL-
. 14_ 14 l y s m e - 1 - C. 
Uniformly labeled glucose was chosen for the f i r s t experiment 
because i t was expected that s ignif icant labeling would appear in each 
of the hydrolysis products. This precursor was used la rge ly to tes t the 
methods of separating the hydrolysis components and counting the frac­
tions in order to locate the radioactive ones. Except for the fact that 
no urea was found, every hydrolysis component was s ign i f ican t ly labeled. 
Interesting data were obtained from this experiment. I t was found that 
20 
those hydrolysis components that were the closest to glucose meta-
b o l i c a l l y contained more rad ioac t iv i ty than those components that would 
require a large number of steps to be synthesized from glucose. The 
only exception was a,8-diaminopropionic acid, which contained roughly 
twice the ac t iv i ty per carbon atom that serine contained. This situa­
tion could arise i f at least part of the serine to be incorporated into 
viomycin as a seryl residue had been bound to a c e l l wall pr ior to the 
addition of the labeled glucose, so that i t would be available for in­
corporation as a serine residue, but not available for conversion to 
diaminopropionic acid. 
14 . 14 In the experiments with Z3L-serine-3- C and DL-sevme-1- C as 
precursors, the serine isolated from the hydrolysate contained the 
largest amount of a c t i v i t y , as might be expected. With DL-serine-3-
14 
C as the precursor, 42 per cent of the to ta l ac t iv i ty hydrolyzed 
appeared in the serine fract ions, while 48 per cent of the t o t a l 
ac t iv i ty was found in the serine isolated from the viomycin with DL-
14 
serine-1- C as the precursor. Rela t ive ly high ac t i v i t y was also found 
in the diaminopropionic acid fract ions, suggesting that serine might be 
converted d i rec t ly into diaminopropionic acid. The ac t i v i t y of the 
14 
carbon dioxide produced m the acid hydrolysate from £>L-serine-l- C 
14 
was 5.5 times the ac t i v i t y of the carbon dioxide from DL-semne-3- C, 
14 
even though the viomycin from Z?L-serine-3- C was twice as radioactive 
14 
as the viomycin from Z?L-serme-l- C. This result is consistent with 
several of the common b i o l o g i c a l degradations serine undergoes: the 
conversion of a phosphatidylserine to a phosphatidylethanolamine by 
21 
decarboxylation, or conversion to pyruvate and decarboxylation of the 
*
 4 2 
pyruvate. 
14 
The 3 - ly s ine derived from Z?L-serine-3- C also contained a s i g ­
nif icant l e v e l of a c t i v i t y , but very l i t t l e was noted in that derived 
14 
from ffi-serine-l- C. This is consistent with at least one of the known 
43 
biosynthetic pathways to lys ine . 
Since there was evidence that 3 - l y s i n e could be obtained from 
34 36 
lysine in strains of Clostridium and Escherichia^ ' the next experi-
14 
ment, using DL-lysine-2- C as the precursor, was designed to determine 
whether lysine is the precursor of 3 - l y s ine in viomycin. A to ta l of 41 
per cent of the ac t iv i ty of the viomycin hydrolyzed appeared in the 8 -
lysine fract ions, c lear ly indicating that 8 - ly s ine is derived from 
lysine in viomycin biosynthesis. Both the serine and diaminopropionic 
acid fractions also contained r e l a t i v e l y high a c t i v i t i e s . The ra t io of 
the ac t i v i t y of the diaminopropionic acid to the ac t iv i ty of the serine 
fractions was 0.24, the same value that was obtained when £>L-serine-
14 . . 
1- C was used as a precursor. A direct pathway from lysine to serine 
would seem to be indicated by the r e l a t i v e l y high incorporation of 
. . . . 14 
a c t i v i t y in serine when Z?L-lysme-2- C was used as a precursor. 
14 
£>L-Lysine-l- c was also studied as a precursor in viomycin b i o -
14 
synthesis. So with the lys ine-2- C experiment, the 8 - ly s ine was the 
most heavily labeled, while both the serine and the diaminopropionic 
acid were labeled s ign i f ican t ly , but to a lesser extent than 8 - l y s i n e . 
The labeling patterns of the samples of serine and diaminopro­
pionic acid that showed s ignif icant incorporation were determined in 
order to demonstrate more conclusively that serine is the precursor of 
22 
diaminopropionic acid in viomycin. The samples of serine and diamino-
14 14 
propionic acid from the precursors glucose-U- C, se rme-1- C, senne-
14 14 14 3- C, lysine-2- C, and lys ine -1 - C were subjected m the degradative 
reactions described ea r l i e r . The results are'shown in Table 1. 
Table 1. Labeling Patterns of Serine and Diaminopropionic Acid (DAPA) 
Derived from Labeled Viomycin as Per Cent of Specific A c t i v i t y 
of Precursor Samples of Glucose-U- 1 4 C, Z ^ - S e r i n e - l - 1 ^ DL-
Serine-3- l t + C, Z?L-Lysine-2- 1 4 C , and £>Z,-Lysine-l-11+C 
Sample 
Per Cent 
Ac t iv i t y 
at G-l 
Per Cent 
Activi ty 5 ' 
at C-2 
Per Cent 
A c t i v i t y 
at C-3 
Precursor Glucose-U-
Isolated Serine 
Isolated DAPA 
14. 
Precursor Serine-1-
Isolated Serine 
Isolated DAPA 
Precursor Serine-3-
Isolated Serine 
Isolated DAPA 
Precursor Lysine-2-
Isolated Serine 
Isolated DAPA 
Precursor Lysine-1-
Isolated Serine 
Isolated DAPA 
14. 
14, 
14, 
14, 
32.6 
34.4 
99 
98 
96 
7, 
7. 
9, 
2.4 
2.1 
98.6 
99 .1 
33.1 
31.0 
0.1 
1.1 
2.7 
62.9 
61.0 
1.4 
0.9 
34. 3 
34.6 
0.0 
0.7 
1.0 
91.8 
91.9 
89.7 
34. 7 
36.9 
0.0 
0.0 
"Determined by difference: % C-2 = 100% - (% C-l + % C-3) . 
23 
Examination of the results in this table reveals that the agree­
ment of the labeling patterns between serine and diaminopropionic acid 
in each case is v i r tua l ly ident ica l . These results strongly suggest 
that the serine unit is the direct biosynthetic precursor of the dia­
minopropionic acid unit. I t i s possible that aminomalonic acid semi-
aldehyde is an intermediate in this conversion as was suggested by Rein-
29 
bothe, but other intermediates may also be possible. Another possible 
mechanism would involve direct addition of ammonia to serine in a manner 
analogous to the synthesis of cysteine from serine by addition of hydro­
gen sulfide in a reaction catalyzed by serine sulfhydrase, a yeast 
44 45 
enzyme, as shown in Equation 4. 9 
H O r V 2 + H 2 S — H S 1 + H 2 0 (4) 
| j | H sulfhydrase N H 2 
The label ing patterns of the serine and diaminopropionic acid 
14 
samples from viomycin with lys ine-2- C as the precursor are interesting 
in that the distribution of labeling was found to be two-thirds at the 
C-2 posit ion and one-third at the C-3 posi t ion. A conceivable pathway 
is shown by Equations 5, 6, and 7. 
N H 2 
I + CA . fragment (5) 
14 
Lysine-2- C 
C 0 2 H 
Glycine-2-^0 
24 
NH2 H 
transamination !£is. ! / 2 °9 ^ 
X 0 2 H — CT X 0 2 H ^ H C 0 2 H + C 0 2 ( 6 ) 
+ H C 0 2 H HCf Y 4 4 W 
NHo C 0 2 H ™Z 
Serine 
A l l transformations shown except the one from lysine to glycine are 
46 . 
known. The reversible mterconversion of glycine and serine is wel l 
known, and i t i s reasonable to expect that there would be more unlabeled 
formate available for reaction than unlabeled g lyc ine . The per cent 
a c t i v i t y would then be expected to be greater at C-2 than at C-3. 
14 
The serine and diaminopropionic acid derived from l y s m e - 1 - C 
14 
both had almost a l l of the C ac t i v i t y located m the C-l posi t ion, as 
can be seen from the results in Table 1. These results are completely 
in accordance with Equations 5, 6, and 7, as the only source of a c t i v i t y 
would be the carboxyl carbon of the g lycine . 
Degradation of the labeled 3-lysines isolated from the viomycins 
14 14 derived from lys ine-2- C and lys ine -1 - C was accomplished as described 
14 
ea r l i e r . The degradation of the 3-lysine from the lys ine-2- C indicated 
that 0.8 per cent of the ac t i v i t y was at the C-l posi t ion, 84.3 per cent 
at the C-2 posi t ion, and the remainder at the C-3 through C-6 posi t ions. 
14 
Degradation of the 3-lysme from the l y s m e - 1 - C indicated that 88.3 
per cent of the ac t i v i t y was at the C-l posi t ion. The other positions 
were not counted, since these degradation reactions have low y i e l d s . 
25 
These results indicated that lysine can indeed be a direct precursor of 
8-lysine in viomycin biosynthesis. 
14 
£>L-Arginine-5- C was investigated as a precursor, and i t was 
found that s ignif icant a c t i v i t y appeared only in the viomycidine and 
isoviomycidine fractions and in certain fractions that fol low viomy­
cidine. These fractions apparently contain compounds more basic than 
viomycidine, and i t would appear that these compounds are peptides 
which contain the viomycidine residue. One of these compounds was 
13 15 
v ioc id i c acid (5_), which has already been described. 9 
Several facts support the suggestion that arginine is the pre­
cursor of the viomycidine residue in viomycin. The* extremely high l e v e l 
14 
of a c t i v i t y found in the viomycidine fractions for the arginine-5- C 
experiment compared to the low leve l s of a c t i v i t y found in viomycidine 
fractions from a l l other precursors investigated is s igni f icant . The 
14 
next most act ive viomycidine sample was derived from the glucose-U- C 
experiment, which contained less than 3 per cent of the a c t i v i t y of the 
14 
viomycidine from arginine-5- C. I t is interesting to note that a rg i ­
nine and viomycidine are both guanidino amino acids, and that their 
molecular formulas d i f f e r by only four hydrogen atoms. 
14 
Each of the precursors £>L-glutamic-3,4- C acid, Z?L-glutamic-5-
14 14 14 
C acid, Z?L-aspartic-4- C acid, sodium acetate-2-" C, sodium acetate-14 14 14 14 1- C, g lyc ine -1- C, sodium bicarbonate- C, and sodium formate- C 
gave very low incorporation of a c t i v i t y into viomycin, and none of the 
hydrolysis products showed s ignif icant a c t i v i t y . 
The purposes of this research were twofold: f i r s t , to continue 
the investigations into the biosynthetic pathways leading to viomycin by 
26 
studying several suspected biological precursors of the amino acids and 
other components in viomycin; and second, to further investigate the 
chemistry of the intact viomycin molecule, derivatives of viomycin, and 
their hydrolysis products. 
27 
CHAPTER I I 
EXPERIMENTAL 
Apparatus and Techniques 
Spectra 
Nuclear magnetic resonance spectra (60 MHz) were obtained using 
Varian Associates Models A-60A and A-60D spectrometers equipped with a 
variable temperature attachment. Chemical shif t values are reported in 
x units (x = 1 0 - 6 ) . Internal standards used were tetramethylsilane 
(TMS) or sodium 2,2-dimethyl-2-silapentane-5-sulfonate (DSS). 
A l l low resolution mass spectral data were obtained using a 
Varian Associates Model M-66 mass spectrometer. Exact mass determina­
tions were obtained by l inear interpolation between ions of an internal 
standard of known mass. Intensity values of individual peaks were 
determined by averaging the intensi t ies obtained from several scans. 
Infrared spectra were obtained using Perkin-Elmer Models 457 and 
137 spectrophotometers. The spectra of solids were obtained from potas­
sium bromide pe l le t s pressed at 2500 psig. 
Ul t rav io le t spectra were obtained using a Cary Model 14 spectro­
photometer. Matched 1.0 cm quartz ce l l s were used. The spectra were 
recorded as solutions in d i s t i l l e d water, 0.1 N hydrochloric acid, or 
0.1 N sodium hydroxide solution, except where otherwise noted. 
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Chromatography 
Thin layer chromatography was used for qual i ta t ive analysis, and 
47 
the plates were prepared as described previously. Ninhydrin spray 
reagent was used for visual izat ion of spots corresponding to amino 
48 
acids. Weber's reagent, as previously described, was used for v i sua l i -
, 48 
zation of spots corresponding to guanidine and guanidino compounds; 
p-dimethylaminobenzaldehyde reagent was used to visual ize spots corre-
48 
sponding to urea. Ul t rav io le t lamps ( 2 5 4 nm and 366 nm f i l t e r s ) were 
also used for visual izat ion of spots on t i c plates coated with s i l i c a 
ge l HF 254 ( B r i n k m a n Instruments, I n c . ) . 
Paper chromatography was used for both qual i ta t ive analysis and 
preparative separations. Chromatographic papers Whatman Number 1 and 
Whatman Number 3MM were used for qual i ta t ive analysis, and Whatman 
Number 17 was used for preparative chromatography. A l l paper chromato-
grams were developed by the descending solvent technique in a glass tank 
that was fu l ly equilibrated between solvent and vapor. 
A B e c k m a n M o d e l R e l e c t r o p h o r e s i s a p p a r a t u s , Beckman number 
3 2 0 0 4 6 , was used for electrophoretic separations. A l l analyses were done 
using Beckman number 319 328 paper str ips and Beckman number 319 329 paper 
wicks. A l l electrophoresis experiments were done at a constant vol tage . 
The vo l tage , distance of migration from the o r ig in , direct ion of migra­
t ion , buffer used, and the time of the current flow are presented with 
each experiment. Detection of the bands on the strips was accomplished 
in the same manner as for thin layer and paper chromatography. 
Gel f i l t r a t i o n chromatography was used for purif icat ion and 
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separation purposes using Sephadex G-15 (Pharmacia Fine Chemical, I n c . ) 
47 
prepared and used as described previously. 
Ion exchange resins were used for the conversion of peptide salts 
into their free base forms, exchange of the anions in peptide sa l t s , 
and for the separation of amino acids and peptides in hydrolysates. The 
resins used were regenerated and used as described p r e v i o u s l y . ^ T h e 
following abbreviations are used: IR-45(0H~), IR-45(S0~), and 
IR-45(C1 ) for Amberlite anion exchange resin 45 in the hydroxyl, sul­
fa te , and chloride phases, respect ively; IRC-50(H +) for Amberlite cation 
exchange resin 50 in the hydrogen phase; and Dowex 50(H + ) for Dowex 
50W X-8 (100-200 mesh, Baker reagent 19 30) in the hydrogen phase. 
Miscellaneous 
Optical rotations were determined using a Bellingham and Stanley 
Model No. 39 7619 polarimeter with the sodium D l ine as a l igh t source. 
Unless otherwise stated, a l l concentrations and evaporations were 
performed using a modified, a l l glass Rinco (Model VE-1000A) rotary 
evaporator at water aspirator vacuum and at temperatures not in excess 
of 60°C. 
A l l melting points were obtained using a Kofler hot stage and are 
corrected. Microanalyses were performed by Bernhardt Laboratories 
(Mulheim, West Germany). A l l bioassays were conducted by Dr. Paul D. 
Shaw of the University of I l l i n o i s , Urbana, I l l i n o i s . 
A Welsbach Model T-408 ozone generator was used in a l l ozonolyses. 
Ozone was generated at 90 vol ts with a flow rate of 0.5 standard l i t e r s 
per minute ( s . l . p . m . ) and a pressure of 8 psig. 
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A GM Instrument Company, Inc. Model VE-2002-B-24 automatic frac­
tion col lec tor was used to co l lec t timed fractions from chromatography 
columns. 
A l l ca ta ly t ic hydrogenations were performed at atmospheric pres­
sure and room temperature; the data were corrected to standard condi­
tions . The catalyst was a 10 per cent platinum on carbon mixture 
(Engelhard Industries, I nc . , Lot No. C-3246) and was used in a 50 per 
cent aqueous acet ic acid solvent. The catalyst-solvent mixture was 
equilibrated with hydrogen for 12 hr or more before introduction of the 
sample. 
Techniques for Liquid Sc in t i l l a t ion Counting 
A l l counting of radioactive samples was done using a Packard 
Tri-Carb Model 3375 Liquid Sc in t i l l a t ion Spectrometer. A l l samples 
were counted using the green channel (with the blue channel as a check) 
with the C-D channel selector in (C:050, D:1000). Since no radioactive 
14 
isotopes other than C were present, these discriminator settings gave 
the widest possible energy "window" for counting, thus improving the 
counting e f f i c i ency . The print-out was normally set to print AES r a t i o , 
sample number, time, gross counts for the green channel, and net counts 
per minute (cpm) for the green channel. Occasionally, the blue channel 
was also printed out to cross-check the results obtained on the green 
channel. The following d ia l settings were normally made: 
Preset count 900,000 cpm 
Low-level re jec t Off 
Number of counts 1 
Number of cycles 0 0 
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Background counts were determined using a standard series of 
samples made up as close in composition as possible to the samples to 
be counted, but without any rad ioac t iv i ty . These background samples 
were counted several times for 500 min each using the same d ia l settings 
that would be used for radioactive samples, except that the background 
subtraction was set to zero. The average value of the background counts 
was set on the background subtraction d i a l , and the counter was then 
ready for use. 
A toluene-Triton X-100 sc in t i l l a t i on solution (tT21) was used 
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for a l l water-soluble samples. This s c in t i l l a t i on solution was pre­
pared by dissolving 6.9 36 g of 2,5-diphenyloxazole (PPO) and 0.173 g 
of 1,4-bis[2-(5-phenyloxazolyl)]benzene (P0P0P) in two l i t e r s of 
d i s t i l l e d toluene. After solution was complete, 1 kg of Triton X-100 
(Reg. Trademark of Rohm S Haas, I n c . ) purified for l iquid s c in t i l l a t i on 
counting (Packard Instrument Company, I nc . , Cat. No. 6008083) was added 
with s t i r r i ng . The s c in t i l l a t i on solution was then ready for use. 
N o r m a l b a c k g r o u n d c o u n t s f o r this solution were 20 to 30 cpm. 
14 . . 
The s c in t i l l a t i on samples for the determination of C ac t i v i t y 
were made up by di lut ing 250 ul aliquots of the desired sample with 
750 ul of water (dispensed with a continuous flow Cornwall p ipe t to r ) 
in a counting v i a l . Fourteen m i l l i l i t e r s of tT21 s c i n t i l l a t i o n solution 
was then added to the v i a l (dispensed with a 20 ml Lablndustries L / I 
Repipet, Cat. No. 3020-A, set to de l iver 14.0 ml of the so lu t ion) . The 
v i a l was then capped, shaken, and allowed to stand unti l a clear solu­
tion resulted. After being placed in the freezer compartment of the 
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sc in t i l l a t i on spectrometer, a l l samples were allowed to equil ibrate for 
at least 30 min before being counted. 
Counting e f f ic ienc ies were determined by a method different from 
g 
that described by Floyd. Due to d i f f i c u l t i e s with the automatic 
external standardization (AES) system on the s c i n t i l l a t i o n spectrometer, 
the AES rat ios were re l i ab le only over short ranges and were not gen­
era l ly used to correlate quenching with counting e f f i c iency . Instead, 
a standard series of samples containing exactly known amounts of benzo­
ic . . . . 
i c - C acid were made up using water and hydrochloric acid concentrations 
ranging from 0.1 N to 6.0 N. These samples were made up in exactly the 
same manner as the routine counting samples. The per cent counting 
eff ic iency was calculated for each sample in the standard se r ies , and 
these counting e f f ic ienc ies were plotted on a graph versus acid concen­
trat ion (normality) in each sample. Since Floyd has determined the 
normality of the hydrochloric acid required to elute each of the hydro­
lys i s components of viomycin from the long Dowex 50(H + ) column,^ a 
counting ef f ic iency could be determined for each component that i s 
eluted from the column. This method has proven to be far more accurate 
than any other method previously used. 
The to t a l a c t i v i t y (dpm) of each fraction was determined as shown 
in Equation 8. 
(dpm) (cpm/250 ul sample)(4)(no. m i l l i l i t e r s in f rac t ion) 
(counting e f f i c i ency ) 
( 8 ) 
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Fractions containing signif icant amounts of the same hydrolysate 
component were pooled, evaporated to dryness, redissolved in 15 ml of 
water, and lyophi l ized . These samples were saved for pur i f ica t ion , 
14 
counting, and degradation studies to determine the complete C-labelmg 
patterns. 
Chemical Studies 
The Catalytic Hydrogenation of Viomycin 
Several samples of commercial viomycin sulfate were ca ta ly t i ca l ly 
hydrogenated. In a typica l reduction, a quantity of commercial viomycin 
sulfate was placed in a desiccator and dried over Dr ier i te (Hammond 
Drier i te Co. ) under vacuum. This dried material s t i l l contained approx­
imately 10 per cent water, as wel l as some inorganic salts that act as 
buffers in aqueous solution. 
A 6.783 g sample of this material was dissolved in 50 ml of 50 per 
cent aqueous acetic acid. In the meantime, 7.5 g of 10 per cent platinum 
on carbon catalyst was slurried with 250 ml of 50 per cent aqueous 
acetic acid and equilibrated with hydrogen at room temperature and atmos­
pheric pressure. After this time, the viomycin sample was introduced 
with careful exclusion of a i r . This mixture was then s t i r red for 410 
hr, during which time 520 ml of hydrogen (STP) was absorbed by the 
viomycin and the uptake of hydrogen had v i r tua l ly stopped. The catalyst 
was removed by f i l t r a t i o n through a bed of C e l i t e , and the f i l t r a t e was 
evaporated to a colorless g lass . This material was then dissolved in 
50 ml of water and lyophi l ized to give 7.286 g of a white, amorphous 
s o l i d , which was named perhydroviomycin. This material was s t i r red with 
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90 ml of IR-45(0H~) resin unt i l the pH was 5.5. The resin was then 
f i l t e r e d and washed with water; the f i l t r a t e and the washings were 
combined and evaporated to a thin syrup. This was applied to and 
eluted through a column containing 60 ml of IR-45(S0~) with 250 ml of 
water. Lyophil ization of the eluate gave 6.240 g of perhydroviomycin 
as the stoichiometric sulfate s a l t . 
The uv spectra of this material in aqueous solution (pH 5 ) , in 
0.1 N hydrochloric acid, and in 0.1 N sodium hydroxide showed no 
absorption. The i r spe6trum was similar in general appearance to that 
of viomycin. 
The nmr spectrum of perhydroviomycin in deuterium oxide (13 per 
cent, w /v ) was very similar to the spectrum of viomycin, except that 
the prominent absorption at T 1.9 3 in the spectrum of viomycin had com­
ple te ly disappeared. 
Tic analyses of perhydroviomycin using water, 1-butanol:acetic 
acid:water:acetone:3 N ammonium hydroxide ( 9 : 2 : 4 : 3 : 2 ) , and 1-butanol: 
a c e t i c a c i d . - w a t e r ( 4 : 5 : 1 ) e a c h revealed only one ninhydrin pos i t ive 
spot, which had a different R^ value from viomycin in the f i r s t two 
systems, but a similar R value in the third system. Nessler 's and p-
dimethylaminobenzaldehyde reagents revealed no ammonium ion or urea 
present in the perhydroviomycin preparation. 
The b io log ica l ac t iv i ty of this material was measured by the zone 
inhibi t ion method using B. subtilis and was found to be approximately 30 
per cent as act ive as viomycin. 
As a further check of the purity of perhydroviomycin, 2.371 g of 
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perhydroviomycin sulfate was subjected to ge l f i l t r a t i o n chromatography 
over a 550 cm x 1.9 cm Sephadex G-15 column. Approximately 1400 ml of 
wet Sephadex was slurried in one l i t e r of 0.01 N formic acid, poured into 
the column, and allowed to se t t l e by gravi ty for two days. The perhydro­
viomycin was dissolved in 10 ml of 0.01 N formic acid and was introduced 
onto the column. The column was eluted with 1800 ml of 0.01 N formic 
acid, and 15 ml fractions were co l lec ted . The fractions were individu­
a l ly lyophi l i zed , and a weight curve was plotted (Figure 1 ) . A to ta l 
800 
40 44 48 52 
Fraction Number 
56 60 
Figure 1. Weight Curve for the Sephadex 
Chromatography of Perhydroviomycin 
of 2.190 g of material (92.4 per cent) was recovered, of which 93 per 
cent was homogeneous, giving a Gaussian peak in the weight curve. 
Bioassay of each fraction in the peak revealed an average ac t i v i t y of 
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30 per cent of the ac t i v i t y of commercial viomycin. The uv spectra of 
each of the fractions in water showed no absorption except end absorp-
1% 
tion (E ° less than 7 ) . 1 cm 
Hydrolysis of Perhydroviomycin 
Perhydroviomycin samples were hydrolyzed in much the same manner 
as previous samples of viomycin,^ except that the carbon dioxide pro­
duced was col lec ted for weight determination. In a typica l experiment, 
2.890 g of perhydroviomycin was hydrolyzed using 6 N hydrochloric acid 
g 
and a nitrogen purge. A t-butyl alcohol trap, a cold trap, and a tube 
containing magnesium perchlorate were added to the hydrolysis apparatus 
to remove hydrogen chloride, hydrochloric acid, t-butyl chloride, and 
water vapor from the gas stream. A tube containing Ascarite (Arthur H. 
Thomas Co.) and a small amount of magnesium perchlorate was used to trap 
the carbon dioxide. The increase in weight of this tube was taken as 
the net carbon dioxide produced. A background weight was determined by 
bubbling nitrogen through a hydrolysis mixture that contained only 6 N 
h y d r o c h l o r i c a c i d , under t h e usual conditions. Known samples of viomy­
cin were hydrolyzed under the same conditions; approximately 75 per cent 
of the theoret ical quantity of carbon dioxide was trapped. The carbon 
dioxide trapped from the perhydroviomycin hydrolysate was 74.8 per cent 
of the theoret ical amount expected. 
The hydrolysis mixture was removed from the steam bath and was 
evaporated to a thin syrup. Excess hydrochloric acid was neutralized 
to pH 4 with IR-45(0H ) resin. The resin was then f i l t e r e d and washed 
wel l with water. The f i l t r a t e and washings were combined and 
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concentrated to a volume of approximately 5 ml. This was chromatographed 
over the long Dowex 50(H ) column previously described by Floyd. Four 
hundred fractions were col lected and were tested with ninhydrin, Nes-
s l e r ' s , and Weber's reagents to detect amino acids, ammonium ion, and 
guanidino compounds, respect ive ly . The fractions col lected from this 
column and the ident i t ies of the hydrolysate components are shown in 
Table 2. Each of the ninhydrin pos i t ive fractions was lyophi l ized and 
the weights were recorded. The to ta l weight of each component i s also 
given in Table 2. 
The acid hydrolysate of perhydroviomycin was subjected to t i c 
analysis in the solvent systems previously mentioned, with the addi­
t ional system: t-butyl a lcohol :acet ic acid:water:5% ammonium hydroxide 
( 5 : 4 : 1 : 3 ) . Serine, alanine, diaminopropionic acid, and 8-lysine were 
pos i t ive ly iden t i f i ed in this way by direct comparison with known com­
pounds and by comparison of colors given with the ninhydrin reagent. 
Nessler 's reagent revealed the presence of ammonium ion in the alanine 
f ract ions , but no urea was detected in any fraction or on t i c analysis 
by use of p-dimethylaminobenzaldehyde reagent. 
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Viomycidine and the related capreomycidine were found to give 
rather dif ferent colors with both Weber's reagent and ninhydrin reagent. 
Samples of known viomycidine and capreomycidine were compared with the 
unidentified guanidino-containing material from the acid hydrolysate of 
perhydroviomycin. Both the ninhydrin and Weber tests of the unidenti­
f i ed material c losely matched the colors given by capreomycidine on t i c 
p la tes . Tic analysis of this material , viomycidine, and capreomycidine 
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Table 2. Hydrolysis Components of Perhydroviomycin 
Fractions Identi ty Weight (mg) a Millimoles R a t i o a 
142-157 Serine 477(746) a 3.38 2.00 
185-198 Alanine 160(249) b 1.80 1.06 
188-197 Ammonium Chloride 99* 1.88 1.11 
265-276 Diaminopropionic Acid 304(482) a 2.17 1.28 
282-298 3-Lysine 650 c ( 1 ) 
303-321 Capreomycidine 320 c ( 1 ) 
Weights in parentheses are weights of the lyophi l ized 
fract ions; Floyd 6 determined that serine and diaminopropionic 
acid both gain about 36 per cent in weight upon lyophi l iza t ion 
from 4.0 N hydrochloric acid. The weights and number of m i l l i ­
moles shown have been corrected for th i s . 
Alanine and ammonium ion overlap on the column; the 
weight shown for ammonium chloride is the weight los t from the 
alanine fractions upon removal of ammonia. 
c 
No weight gain data are available for 6-lysine and cap­
reomycidine; the ra t io shown is inferred by comparison of the 
weights obtained from this experiment with those from other 
experiments. 
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in the usual solvent systems revealed that the guanidino material from 
perhydroviomycin was ident ica l with capreomycidine. 
No other major components were found in the acid hydrolysate of 
perhydroviomycin. Except for the absence of urea, these results are in 
13 20 
agreement with those found by Johnson and coworkers. ' 
In order to obtain an accurate weight for the alanine, i t was 
necessary to remove the ammonium chloride which was found in most of 
the alanine-containing fract ions. A l l of the alanine-containing frac­
tions were combined, lyoph i l i zed , and stored under vacuum to remove 
a l l traces of excess hydrochloric acid. The dry powder (348 mg) was 
slurr ied with 20 ml of dry IR-45(0H~) resin and 50 ml of absolute 
ethanol and evaporated to dryness. This procedure was repeated four 
times. After the last evaporation, 50 ml of 0.2 N hydrochloric acid 
was added to dissolve the alanine. A Nessler 's test of this solution 
was negat ive, showing that the ammonium ion had been, removed. The resin 
was f i l t e r e d and washed with 50 ml of 0.2 N hydrochloric acid. The f i l ­
t rate and washings were combined and lyophi l ized to dryness. A to t a l of 
249 mg of alanine was i so la ted . The loss in weight of 99 mg was 
assumed to be the weight of ammonium chloride that was removed. A 
weight gain of 36 per cent was assumed for the alanine, based on the 
behavior of ser ine , in the mole r a t io calculations. A small amount of 
this alanine was rec rys ta l l i zed from ethanol-water and was used for an 
22 
opt ica l rota t ion. The alanine was found to be op t ica l ly inact ive ( [c t ]^ 
0° ( ± 2 ° ) , c , 0.75 in water, c , 0.44 in g l a c i a l acet ic acid; l i t . values 
25 2' ] D + 1.8°, e , 2 in water, [ a ] ' 5 for L-alanine: [ a  c + 33.0°, a9 2 in g la -
c i a l acid ) . 
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Biosynthetic Studies 
Preparation and Purif icat ion of Labeled Viomycin Samples 
Samples of viomycin investigated in this study were produced from 
an i so la te of Streptomyoes griseus var. purpurea at the University of 
I l l i n o i s under the direct ion of Dr. Paul D. Shaw. Production of viomy-
cin was achieved as previously described. Each batch of viomycin 
produced was assayed by uv spectrophotometry, b i o l o g i c a l l y by the zone 
inhibit ion method using B. subtit-is3 and by thin laiyer chromatography 
in the solvent system: t-butyl alcohol:acetone:acetic acid:5 per cent 
ammonium hydroxide:water ( 5 : 5 : 5 : 3 : 1 ) . 
15 
Seven radioactive compounds and three compounds labeled with N 
2 
and H suspected of being precursors of viomycin were added to the cul­
ture medium in separate experiments, and the viomycin that was produced 
was isolated and pur i f ied . The precursors studied and thei r respective 
run numbers are l i s t ed in Table 3. This table also summarizes the data 
obtained by private communication from Dr. Paul D. Shaw concerning the 
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samples of viomycin produced using these compounds as precursors. 
Hydrolysis and Chromatographic Techniques for Labeled Viomycin Samples 
Hydrolyses of radioact ively labeled viomycin were routinely car­
r ied out as fo l lows: the sample of radioact ively Labeled viomycin was 
weighed and diluted with one to two grams of commercial viomycin (Parke, 
Davis, and Company) that had been dried to constant weight in a vacuum 
desiccator at room temperature. This sample was then dissolved in 80 ml 
of 6 N hydrochloric acid, placed under a reflux condenser, and heated at 
steam bath temperature for 20 hr. Nitrogen was slowly bubbled through 
Table 3. The Production of Labeled Viomycin 
Run 
No. Precursor 
Precursor 
Added 
Viomycin 
Isolated 
Weight (mg) 
1 4 c 
A c t i v i t y 
(dpm) 
Per Cent 
Incorporation 
15 14 £>L-Arginme-amidine- C 4 . 9 3 X 1 0
8
 dpm 168 9 . 2 2 X 1 0 6 5.40 
16 £>L-0rnithine-l- 1 I +C 
o 
6.86x10 dpm 200 1 . 7 2 X 1 0 7 2.32 
17 14 Z)L-Arginine-1- C 7.06xl0
8
 dpm 156 1 . 2 8 X 1 0 7 2.34 
18 Z)-Glucose-U- 1 4C JO , 2.16x10 dpm 1061 1.55xl0
8 0.78 
19 14 L-a ,8-Diammopropionic-U- C Acid 
2.09xio 7 dpm 186 6 . 5 5 X 1 0 5 3.74 
20 14 L-B-Lysme- C 
( label ing pattern undetermined) 
1 . 4 3 X 1 0 7 dpm 157 1 . 0 7 X 1 0 6 8.15 
21 14 L-Viomycidme- C 
( label ing pattern undetermined) 
6.92xl0 6 dpm 319 7 . 5 8 X 1 0 4 1.09 
22 15 L-Lysine-"1" N 0.296 mmoles 71 - 3.54
a 
23 15 L-Serine- N 0.438 mmoles 142 - 2.26
a 
24 3,3-Dideuterioserine 0.762 mmoles 114 - 1.38 b 
Average values based on previous experiments using C-labeled precursors. 
i 14 6 Based on an experiment using serine-3- C (Run No. I I , Floyd ) . 
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the hydrolysis solution and into a trap containing approximately ten 
m i l l i l i t e r s of a one molar solution of the hydroxide of Hyamine 10-X 
(Reg. Trademark of Rohm £ Haas, I n c . ) in methanol that was connected 
to the reflux condenser. The carbon dioxide released during hydrolysis 
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was trapped as the carbonate sal t of Hyamine hydroxide. For counting, 
the methanolic solution of Hyamine hydroxide was diluted to 50.00 ml 
with methanol. A 250 y l aliquot was used for counting and was treated 
as already described. 
After the hydrolysis was completed, the hydrolysate was concen­
trated to a syrup. Excess hydrochloric acid was removed under vacuum. 
The syrup was then dissolved in 20 ml of water and IR-45(0H ) resin was 
added unti l the pH was about f i v e . The solution was f i l t e r e d , and the 
resin was washed with four to s ix 20 ml portions of water. The f i l ­
t ra te and washings were then combined and concentrated to a volume of 
2 to 5 ml; the sample was then ready to be chromatographed. 
T h e c o l u m n u s e d t o c h r o m a t o g r a p h t h e v i o m y c i n h y d r o l y s a t e w a s 
the same one u s e d b y F l o y d . ^ The Dowex 50(H + ) resin was used as 
g 
described previously, except that only 200 ml of water was added to 
the wet res in . This allowed the entire column, which had a volume of 
1750 ml, to be f i l l e d in one pouring, resulting in a more evenly d is ­
tributed column. The resin was allowed to s e t t l e by gravi ty for at 
least four hours; the stopcock was then opened, and the excess water was 
drained. The column was then ready for use. 
The hydrolysate sample was pipetted onto the top of the column 
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and washed onto the resin with a small amount of water. The column was 
then eluted by gradient elution chromatography with hydrochloric acid as 
described previously.^ 
The automatic fraction co l lec tor (GM Instrument Company, Inc. 
Model VE-2002-B24) was modified to a capacity of 234 18 x 150 mm test 
tubes. Fractions of approximately 15 ml each were col lected using the 
automatic timer function set for 15 min fract ions. The column flow rate 
was adjusted per iodica l ly to 12 drops per minute in order to maintain 
15 ml f ract ions . The modifications were necessary in order to increase 
the r e l i a b i l i t y of the fraction col lec t ing system. 
Although the column was designed to separate the hydrolysate of 
f i v e grams of viomycin, samples as small as 100 mg were chromatographed 
with excel lent resul ts . 
The quantities of labeled and unlabeled viomycin hydrolyzed in 
these experiments are l i s t ed in Table 4. 
A summary of the to t a l a c t i v i t i e s found in each of the principal 
fractions from the hydrolysates of the radioact ively labeled viomycins 
is shown in Table 5. 
Plots of r ad ioac t iv i t i e s of the fractions obtained from the 
chromatography of the hydrolysates of these viomycin samples are shown 
in Figures 2 through 8. 
As can be seen from Figures 2-8 and from Table 5, the guanidino 
14 
compounds were s ign i f ican t ly labeled when arginine-amidine- C, orni-
14 14 thine-1- C, and arginine,-1- C were used as precursors. The other 
components of the hydrolysate showed very l i t t l e incorporation from these 
precursors. 
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Table 4. Amounts of Viomycin Hydrolyzed for Each Experiment 
Run 
No. Precursor 
Labeled 
Viomycin" 
(mg) 
Unlabeled 
Viomycin 
Added-
(mg) 
Total 
(mg) 
15 A • • 'j' 14 n Arginine-amidme- C 168 2459 
2627 
16 14 Ornithme-1- C 200 2541 2741 
17 . . 14 Arginme-1- C 156 2233 2389 
18 Glucose-U- 1 4C 1004 0 1004 
19 14 Diammopropionic-U- C Acid 182 1459 1641 
20 14 3-Lysme- C 
( label ing pattern undetermined) 
157 1624 1781 
21 14 Viomycidine- C 
( label ing pattern undetermined) 
319 1028 1347 
22 j . 15M Lysine- N 156 0 156 
23 Serine- N 226 0 226 
24 3,3-Dideuterioserine 170 0 170 
Expressed as milligrams of the sulfate sa l t dried to 
constant weight at 25°C. 
Due to the unavai labi l i ty of C-labeled diaminopropionic acid, 
14 6 3- lysine, and viomycidine, the glucose-U- C experiment (Run No. 1) 
was repeated using a larger quantity of more highly labeled glucose (Run 
No. 18) . This preparation was hydrolyzed without the addition of un­
labeled viomycin. The diaminopropionic acid, 3- lysine, and viomycidine 
components were isolated and separately used as precursors for 
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Table 5. Summary of the Principal Fractions from the 
Hydrolysate of Radioactively Labeled Viomycin 
Total 
Weight Ac t iv i t y 
Precursor Fractions Identi ty (mg) (dpm) 
14 
Arginine-amidine- C (Run No. 15) 
132-142 Serine 784 12,000 
209-227 
-
128 286,700 
240-251 DAPA 304 121,800 
253-268 8-Lysine 664 89,500 
269-284 Isoviomycidine 123 999,300 
285-304 Viomycidine 283 2,276,000 
305-325 Peptides 40 320,000 
326-358 Peptides 15 816,900 
359-400 Peptides 253 1,269 ,000 
-
Carbon dioxide 
-
87,000 
14 
Ornithine-1- C (Run No. 16) 
165-177 Serine 450 111,000 
200-208 
-
43 32,000 
260-272 
-
267 109 ,500 
292-312 DAPA 221 366,000 
314-332 8-Lysine 777 97,500 
333-349 Isoviomycidine 131 907,000 
350-365 Viomycidine 361 3,740,000 
366-400 Peptides 81 477,000 
401-420 Peptides 74 245,000 
421-446 Peptides 183 1,532,000 
-
Carbon dioxide 
-
182,000 
14 
Arginine-1- C (Run No. 17) 
191-205 Serine 871 151,200 
324-335 DAPA 444 66,100 
343-355 8-Lysine 641 48,000 
360-387 Isoviomycidine 202 1,275,000 
388-405 Viomycidine 320 2,742,000 
411-425 Peptides 61 433,500 
435-451 Peptides 42 305,000 
-
Carbon dioxide 
-
182,000 
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Table 5. Summary of the Principal Fractions from the 
Hydrolysate of Radioactively Labeled Viomycin 
(Continued) 
Precursor Fractions Identi ty 
Weight 
(mg) 
Total 
A c t i v i t y 
(dpm) 
Glucose-U- 1 4C 
(Run No. 18) 
L-a, 8-Diaminopropionic-U-
lkC Acid (Run No. 19) 
14 
L-8-Lysine- C 
(Labeling pattern 
undetermined) 
(Run No. 20) 
14 
L-Viomycidine- C 
(Labeling Pattern 
undetermined) 
(Run No. 21) 
93-101 
155-168 
169-297 
300-310 
311-316 
317-329 
330-345 
346-370 
371-390 
391-420 
421-454 
144-154 
278-289 
392-410 
Serine 
DAPA 
8-Lysine 
Isoviomycidine 
Viomycidine 
Peptides 
Peptides 
Peptides 
Carbon Dioxide 
Serine 
DAPA 
Carbon Dioxide 
202 
A 
141 
A 
175 
92 
280 
8-Lysine 
Carbon dioxide 
417 
254,000 
40,000 ,000 
9,380,000 
24,600 ,000 
1,010,000 
15,100 ,000 
2,590,000 
7,470 ,000 
2,070,000 
133,000 
6 ,860 ,000 
12,700,000 
22,000 
233,000 
116 ,000 
1,030 ,000 
5,500 
No s ignif icant ac t i v i t y in any f ract ion. 
Not isolated 
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FRACTION NUMBER 
Figure 2. A c t i v i t y Curve for the Hydrolysate of Viomycin 
from £>L-Arginine-Amidine-1 1 +C (Run No. 15) 
FRACTION NUMWft 
Figure 3. A c t i v i t y Curve for the Hydrolysate of Viomycin 
from £L-0rnithine-l- 1 1 + C (Run No. 16) 
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Figure 4. A c t i v i t y Curve for the Hydrolysate of Viomycin 
from £L-Arginine- l - 1 1 + C (Run No. 17) 
100000 
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Figure 5. A c t i v i t y Curve for the Hydrolysate of Viomycin 
from £>L-Glucose-U-11+C (Run No. 18) 
49 
o lOOOl 
SOOr 
TO 100 I S O 160 l»0 220 250 2K> 510 » « 0 370 400 < 
FRACTION NUHKR 
Figure 6. A c t i v i t y Curve for the Hydrolysate of Viomycin for 
L-a,8-Diaminopropionic-U-ll+C Acid (Run No. 19) 
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Figure 7. A c t i v i t y Curve for the Hydrolysate of 
Viomycin from L-8-Lys ine- 1 4 C (Run No. 20) 
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Figure 8. Ac t iv i t y Curve for the Hydrolysate of Viomycin 
from L-Viomycidine- l l +C (Run No. 21) 
incorporation into viomycin. These viomycin samples were then hydro­
lyzed , chromatographed, and counted (Run Nos. 19, 20, and 21) . 
Determination of the Specific A c t i v i t i e s of the Hydrolysis Components 
from l t f C-Labeled Viomycin Samples 
Diaminopropionic Acid. The lyophi l ized sample of diaminopro­
pionic acid isolated from Run No. 19 was c rys ta l l i zed as described by 
Floyd. A 49.9 mg sample of the crys ta l l ine diaminopropionic acid 
monohydrochloride was dissolved in water and diluted to 5.00 ml. 
A drop of chloroform was added to prevent the growth of mold. A 100 ul 
aliquot was placed in a counting v i a l , and 900 ul of water and 14.0 ml 
of tT21 sc in t i l l a t i on solution were added. The a c t i v i t y was counted as 
usual and the counting ef f ic iency was determined by comparison of the 
AES ra t io with those of solutions of known pH. The spec i f ic a c t i v i t y 
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was calculated from Equation ( 9 ) . 
Q A - (cprcHlO) (q) 
S
'
A
- ~ ( E ) ( c ) ( 9 ) 
where S.A. = spec i f ic a c t i v i t y in dpm/mg 
cpm = ac t iv i ty of sample 
E = counting ef f ic iency of sample 
c = concentration of sample in mg/ml. 
The results are given in Table 6. The remainder of the diaminopro­
pionic acid solution was saved for subsequent degradation studies. 
Viomycidine. Due to the d i f f i c u l t i e s involved in c rys t a l l i z ing 
viomycidine, the viomycidine samples ( i so la ted from Run Nos. 7, 15, 16, 
and 17) were not c rys t a l l i zed . The spec i f ic a c t i v i t i e s were determined 
in another way. Each of the viomycidine samples was dissolved in 15 ml 
of water and lyophi l ized to dryness. The samples were then stored under 
vacuum in a desiccator over Linde 4A molecular seive pe l l e t s (Union Car­
bide Corporation) for four days. The samples were weighed accurately, 
and 10.0 ml of water was added to each one. After each sample was d is ­
solved, 1.00 ml of each one was diluted to 10.00 ml in a volumetric 
f lask. A 250 ul aliquot of each sample was placed in a counting v i a l , 
and 750 ul of water and 14.0 ml of tT21 s c i n t i l l a t i o n solution were 
added. The samples were counted as usual, and the spec i f ic a c t i v i t i e s 
were calculated from Equation 10. Counting e f f i c i enc ies were determined 
in the same manner as for the diaminopropionic acid. 
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where S.A. = speci f ic ac t i v i t y in dpm/mg 
cpm = ac t iv i ty of sample 
E = counting ef f ic iency of sample 
w = weight of sample counted. 
The weight counted, w, was determined by assuming that the to t a l weight 
of the viomycidine sample was accurately diluted 1:400. The 250 ul a l i ­
quot actually counted thus represented 1/400 of the t o t a l sample weight. 
The results are given in Table 6. The unused portions of each viomyci­
dine sample were combined with the or ig ina l samples and re lyophi l ized 
for degradation studies. 
14 
Determination of the C-Labeling Patterns of the Hydrolysis 
Components from Viomycin Samples 
Diaminopropionic Acid: The C-3 Carbon. The solutions of each 
sample of diaminopropionic acid used in the determination of the spe­
c i f i c a c t i v i t i e s were also used in the degradation reactions. For 
s e l ec t i ve ly determining the ac t i v i t y at the C-3 pos i t ion , a periodate 
oxidation was used. For each sample, 2.00 ml of the solution of the 
amino acid was added to a 25 ml Erlenmeyer flask containing 4.5 ml of 
0.5 M acet ic acid-sodium acetate buffer, pH 4.7. To this solution was 
added 2.4 ml of a freshly prepared solution of 0.5 M sodium meta-
periodate (107 mg/ml), and the mixture was allowed to stand at room 
temperature for two and one-half hours. After this time, 2.00 ml of 
an ethanolic solution of dimedone (80 mg/ml of ethanol) was added, 
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and the dimedone der ivat ive of the formaldehyde produced by the per-
iodate oxidation was allowed to c rys t a l l i z e for 20 hr. The crys ta l l ine 
precipi tate was then f i l t e r e d , washed with water, and rec rys ta l l i zed 
from ethanol-water. The rec rys ta l l i zed der ivat ive was f i l t e r e d , washed 
with water, and dried. In calculat ions, one milligram of the dimedone 
der ivat ive of formaldehyde is equivalent to 0.4746 mg of diaminopro­
pionic acid monohydrochloride. 
The radioactive dimedone derivat ives were counted by weighing to 
the nearest tenth of a milligram approximately ten milligrams of the 
crys ta l l ine der ivat ive into a counting v i a l . Fifteen m i l l i l i t e r s of 
tT21 s c in t i l l a t i on solution was added, and the samples were counted 
as usual. The results of these degradations are given in Table 6. 
Diaminopropionic Acid: The C-l Carbon. Although previous 
degradations of serine and diaminopropionic acid used both /7-bromosuc-
cinimide oxidation and ninhydrin oxidation to determine the a c t i v i t y 
6 14 
at C - l , ' only the ninhydrin oxidation was found to give accurate 
and r e l i ab le results from diaminopropionic acid.^ The samples of 
diaminopropionic acid were reacted with ninhydrin by a modification 
41 
of the manometric method of van Slyke and coworkers, as described by 
F loyd . 6 A 50 ul aliquot of the diaminopropionic acid solution was 
added to 3 ml of a 1 M c i t r i c acid-sodium c i t ra te buffer , pH 2.5, in 
the reaction compartment of the reaction f lask. F i f ty milligrams of 
ninhydrin was added to this solution with a spatula; then an empty v i a l 
was put into place in the receptacle , and the flask was t i gh t ly stop­
pered with a rubber serum cap. The reaction flask was allowed to stand 
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in a boi l ing water bath for ten minutes and was then removed and cooled 
to room temperature. As soon as the reaction mixture was cool , 0.5 ml 
of the 1 M solution of the hydroxide of Hyamine in methanol was injected 
into the v i a l and the reaction flask was shaken on a rotary shaker for 
three hours. The small v i a l was then removed and placed in toto in a 
s c in t i l l a t i on v i a l , and 14.0 ml of tT21 s c in t i l l a t i on solution was 
added. The v i a l was allowed to stand in the freezer compartment of 
the s c in t i l l a t i on spectrometer for three days in to ta l darkness before 
accurate counts were obtained. Counting ef f ic iency was determined by 
14 
adding 0.50 ml of a solution of benzoic- C acid in toluene (917 dpm/ 
ml) and comparing the observed count rate with the known disintegration 
ra te . The results of this degradation are given in Table 6. 
The ac t i v i t y at the C-2 position was determined by taking the 
difference between the to ta l a c t i v i t y and the sum of the a c t i v i t i e s at 
C-l and C-3. 
16 
Viomycidine. Nassar has found previously that viomycidine was 
degraded into guanidine and PL-aspartic acid by acetyla t ion, ozonolysis 
of the acetylated viomycidine (hydrogen peroxide workup), and acid 
hydrolysis . Thus the amidine carbon (C-6) was determined d i rec t ly from 
The standard method of numbering the b i c y c l i c ring system of 
viomycidine does not lend i t s e l f to a clear description of the re la t ion­
ships of labeling patterns between the precursors and viomycidine. 
Therefore, the numbering system used in these degradations w i l l re fer to 
the standard numbering system for the arginine and ornithine precursors 
used. The structures and numbering system used for ornithine, arginine, 
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the guanidine produced, and the carboxyl carbon ( C - l ) was determined by 
ninhydrin oxidation of the aspartic acid. The C-5 carbon is apparently 
lost as carbon dioxide during the ozonolysis and subsequent workup, and 
attempts were made to trap and count i t d i r ec t l y . The to t a l a c t i v i t y of 
the other carbon atoms of aspartic acid was determined both by the d i f ­
ference between the ac t i v i t y of the aspartic acid and the ac t i v i t y of 
the carbon dioxide produced in the ninhydrin oxidation of aspartic acid, 
and by direct counting of an aliquot of the residual ninhydrin oxidation 
reaction mixture. 
To the lyophi l ized samples of viomycidine derived from the pre-
14 14 . 14 
cursors arginine-amidine- C, ornithine-1- C, and arg inme-1- C, 30 ml 
of dry pyridine and 30 ml of acet ic anhydride were added, and the solu­
t ion was heated on a steam bath for 20 hr. A drying tube f i l l e d with 
Dr ier i te was used to exclude water vapor from the reaction mixture. 
After this time, the solution was cooled to room temperature, and 60 ml 
of water was cautiously added. The solution was allowed to stand at 
room temperature for 2 hr, and then the dark brown l iquid was evaporated 
and viomycidine are shown in structural formulas 15_, 12_, and 4_, respec­
t i v e l y . 
NH NH 
2 
C 0 2 H C 0 2 H C 0 2 H 
15 12 4 
viomycidine ornithine arginine 
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to a thin syrup. Another 40 ml of water was added and the solution was 
again evaporated to a syrup. 
This syrup was dissolved in 75 ml of 80 per cent formic acid and 
ozone was bubbled through the solution at 0°C for 1.5 hr. After this 
time, 5.0 ml of 30 per cent hydrogen peroxide was added and the solution 
was allowed to stand overnight. Another 5.0 ml of the hydrogen peroxide 
solution was added to the orange solut ion, and the resulting solution 
was allowed to stand for one hour. The solution was then evaporated to 
a syrup, and 75 ml of 6 N hydrochloric acid was added. This solution 
was heated on a steam bath for 22 hr and was then removed from the 
steam bath and s t i r red with a teaspoon of Darco G-60 for 4 to 6 hr. The 
carbon was then f i l t e r e d through a bed of C e l i t e , and the pale yellow 
16 
f i l t r a t e was evaporated to a syrupy crys ta l l ine mass. This material 
was dissolved in 5.0 ml of water, and the guanidine, aspartic acid, and 
other components were separated by preparative paper chromatography. On 
a 17 cm x 46 cm Whatman No. 17 paper s t r ip was placed 0.75 ml of this 
solut ion, and the paper s t r ip was dried thoroughly. The paper was then 
chromatographed using 95 per cent ethanol:3 N ammonium hydroxide ( 5 : 1 ) 
in a descending chromatography apparatus that was in equilibrium with 
the solvent vapor. After the solvent had traveled the ent ire length of 
the s t r i p , the papergram was removed from the tank and dried in a i r for 
several hours. A small test s t r ip was sprayed with Weber's reagent and 
ninhydrin reagent to locate the guanidine and aspart ic«acid bands, 
respec t ive ly . Typica l ly , the guanidine had an value of 0.65, while 
the aspartic acid had an R_ value of 0.15. The test s tr ips were used as 
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a guide for cutting the bands from the paper s t r ips . Only the center 
portions of the bands were used, since guanidine and an unidentified 
band tended to overlap at thei r edges. 
The guanidine-containing str ips and the aspartic acid-containing 
strips were cut into small pieces and separately extracted with three 
30 ml portions of water. The aqueous extracts were separately f i l t e r e d 
and then lyophi l i zed . The samples were then weighed, and 3.00 ml of 
water was added to each one. A 250 ul aliquot was taken for counting as 
usual. Counting e f f i c ienc ies were determined by adding 250 ul of the 
14 
917 dpm/ml solution of benzoic- C acid in toluene used previously to 
the sample v ia l s af ter counting the ac t iv i t y already present, as previ ­
ously described. The results of these degradations are shown in Table 
6. The remainder of each aspartic acid solution was saved for further 
degradation. 
14 
The viomycidine sample derived from arginine-5- C was treated in 
a s l i gh t ly dif ferent manner. The acetylation reaction was carried out 
as d e s c r i b e d f o r t h e o t h e r v i o m y c i d i n e s a m p l e s . S i n c e i t w a s expected 
that the C-5 carbon would be los t during ozonolysis and subsequent work­
up, the ozonolysis react ion, hydrogen peroxide workup, and acid hydroly­
sis steps were arranged such that any carbon dioxide produced would be 
trapped. The o z o n e was passed through the sample solut ion, bubbled 
through a trap containing styrene to remove a l l traces of ozone, and 
then into a trap containing Hyamine hydroxide. After the ozonolysis , 
5.0 ml of 30 per cent hydrogen peroxide was added to the ozonolysis 
reaction mixture using a syringe through a rubber septum. The reaction 
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mixture was allowed to stand overnight at room temperature. An addi­
t ional 5.0 ml of 30 per cent hydrogen peroxide was added using the 
syringe, and a slow purge of oxygen was bubbled through the solution 
and the traps for 2 hr. The ozonized solution was evaporated to a 
syrup, and 75 ml of 6 N hydrochloric acid was added. The solution was 
heated on a steam bath for 22 hr. A slow nitrogen purge was bubbled 
through the hydrolysate and into a trap containing Hyamine hydroxide. 
The Hyamine hydroxide solutions from the ozonolysis and the acid 
hydrolysis traps were separately diluted to 50.0 ml with methanol and 
counted as usual. The to t a l a c t i v i t y of carbon dioxide produced is 
given in Table 6. 
The acid hydrolysate was treated as previously described and the 
results derived from i t are also shown in Table 6. 
The aspartic acid isolated from each of the degradations of the 
14 . 1 4 
viomycidine samples derived from arginme-1- C and orni thme-1- C was 
subjected to further degradation by the ninhydrin oxidation reaction. 
Duplicate determinations were carried out as described for diaminopro­
pionic acid. Samples of 100 ul and 250 ul of each of the aspartic acid 
solutions were used. The Hyamine hydroxide was counted as described for 
14 
the diaminopropionic acid to determine the C ac t i v i t y at C- l . The sum 
of the a c t i v i t i e s at C-2, 3, and 4 was determined by difference between 
the ac t i v i t y of the aspartic acid and that of the carbon dioxide re ­
leased during the oxidation. The reaction solution was also counted as 
a check. The results are given in Table 6. 
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T a b l e 6. S p e c i f i c A c t i v i t i e s and L a b e l i n g P a t t e r n s o f D i a m i n o p r o p i o n i c 
A c i d and Viomycidine D e r i v e d from R a d i o a c t i v e l y L a b e l e d Viomycin 
S p e c i f i c , P e r Cent of 
D C 
A c t i v i t y Carbon A c t i v i t y T o t a l A c t i v i t y 
Compound ( d p m / m g ) a Number P r e c u r s o r (dpm) Per Atom 
D i a m i n o p r o p i o n i c - U 
lkC A c i d (Run N o . 19) 
A r g i n i n e - a m i d i n e - 1 4 C 
(Run N o . 15) 
DAPA 
O r n i t h i n e - l - 1 I + C 
(Run No . 16) 
981.0 C - l 
( 1 3 8 . 2 ) C-2 
C-3 
Viomycidine 8237 C - l 
(1681) C - 2 , 3 , 4 
C-5 
C-6 
Viomycidine 11608 C - l 
(2369) C - 2 , 3 , 4 
C-5 
C-6 
271 
390 
320 
140 
.1820 
1794 
1788 
_c 
113 
27.6 
39.2 
33.2 
7.9 
92 .1 
48.6 
48.4 
3 .1 
A r g i n i n e - l - l l + C 
(Run N o . 17) 
A r g i n i n e - 5 - 1 1 + C 
(Run N o . 7 ) 
Viomycid ine 8166 C - l 
(1666) C - 2 , 3 , 4 
C-5 
C-6 
Viomycid ine 20220 C - l 
( 4126 ) C - 2 , 3 , 4 
C-5 
C-6 
1575 
59 
_< 
89 
170 
,04x10 s 
13 
91.4 
3.4 
5.2 
<1.0 
100* 
<1 .0 
The number in parenthese s i s the s p e c i f i c a c t i v i t y i n dpm p e r ymole. 
These numbers a r e a s s i g n e d as e x p l a i n e d i n the note on p . 5 4, t h i s 
t h e s i s 
The a c t i v i t y i s g i v e n in dpm p e r 250 y l sample o f the s t a n d a r d s o l u t i o n s 
of the v a r i o u s m a t e r i a l s degraded as d e s c r i b e d in the t e x t . 
^ A c t i v i t y not determined and assumed t o be 0 p e r c e n t . 
'Determined by d i f f e r e n c e . 
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14 Since the viomycidine from the ornithine-1- C experiment was not 
14 
labeled predominately at C- l , a sample of the Z?L-ornithine-l- C used as 
the precursor was degraded in order to determine whether the ornithine 
was in fact spec i f i ca l ly labeled at C-l or was more randomly labeled. 
14 
Approximately one microcurie of the Z)L-ornithine-l- C that was 
used as the precursor for Run No. 16 was dissolved in water, and 47.5 
mg of unlabeled L-ornithine monohydrochloride was added. This solution 
was diluted to exactly 5.00 ml, and a 250 ul aliquot was counted. A l i -
quots of this solution were subjected to ninhydrin oxidation by the same 
method used for the diaminopropionic acid and aspartic acid samples. 
The Hyamine hydroxide solutions used to trap the carbon dioxide produced 
were dissolved separately in 14.0 ml of the tT21 s c in t i l l a t i on solution 
and counted. A 250 yl aliquot from each of the residual ninhydrin reac­
tion solutions was dissolved in 0.75 ml of water and 14.0 ml of the 
s c in t i l l a t i on solution and counted. An average of 98.2 per cent of the 
14 
C a c t i v i t y was found at C-l of the ornithine. 
V i o m y c i n f r o m ~^N- a n d D e u t e r i u m - L a b e l e d Precursors 14 15 In addition to the C-labeling experiments, L - lys ine - N (Run 
No. 22) , L - se r i ne - 1 5 N (Run No. 23) , and 3,3-dideuterioserine (Run No. 
24) were also used as precursors. The production data are shown in 
Table 3, and the hydrolysis data are shown in Table 4. The viomycin 
sample from each precursor was hydrolyzed and chromatographed using the 
14 
same techniques as for the C-labeled viomycin samples. Each of the 
hydrolysis components was i so la ted , and the ser ine , diaminopropionic 
acid, and 3-lysine were subjected to low resolution mass spectral 
14 
analysis. The results of this study are given in Table 7. 
T a b l e 7. Low R e s o l u t i o n Mass S p e c t r a l S t u d i e s of the H y d r o l y s i s Components 
of Viomycin from 1 5 N - and D e u t e r i u m - L a b e l e d P r e c u r s o r s 
P r e c u r s o r f o r Per Cent MS m/e I n d i c a t e d Atom Excess 
H y d r o l y s i s Product Viomycin B i o s y n t h e s i s I n c o r p o r a t i o n a V o l t a g e Examined ( P e r C e n t ) 
S e r i n e 
(Run No . 22) 
L y s i n e - N 0.19 30 60/61 1.66 ( 1 5 N ) 
DAPA-HC1 
(Run No . 22) 
L y s i n e - ~ 5 N 0 .04 30 30/31 0.85 at C-3 
59/60 1.82 at C-2 + C-3 
0.97 at C - 2 ° 
6 - L y s i n e 
(Run No . 22) 
S e r i n e 
(Run No . 23) 
Lvsxne- N 
S e r i n e - N 
0.57 
1.00 
70 
30 
56/57 1.86 at e - N H 2 
101/102/103 3.97 at m/e 102 ( N ) 
2.70 a t m/e 103 ( 2 1 5 N ) 
60/61 0 .91 ( 1 5 N ) 
DAPA-HC1 
(Run No . 23) 
s e r i n e - N 0.22 30 30/31 
59/60 
2.92 a t C-3 ( N ) 
4.75 a t C-2 + C-3 
1.83 a t C - 2 C 
3 - L y s i n e 
(Run N o . 23) 
15 
S e r i n e - N 0 .05 
•15. 
70 56/57 0.04 a t e - N H 2 
101/102/103 0.80 a t m/e 102 ( ^ N ) 
2.32 a t m/e 103 ( 2 1 5 N ) 
S e r i n e 
(Run No . 24) 
3 , 3 - D i d e u t e r i o s e r i n e 0 .59 30 60/61/62 1.32 a t M+l ( D ) 
0.65 a t M+2 ( D 2 > 
DAPA-KG1 
(Run No . 24) 
3 , 3 - D i d e u t e r i o s e r i n e 0.14 30 59/60/61 6.15 at M+l ( D ) 
1.78 at M+2 (D ) 
a 14 
Based on the l e v e l of i n c o r p o r a t i o n o b t a i n e d in the a p p r o p r i a t e C - l a b e l i n g e x p e r i m e n t s . 
b 14 14 
A v e r a g e ot r e s u l t s from s e r i n e - 1 - C and s e r i n e - 3 - C i n c o r p o r a t i o n e x p e r i m e n t s . 
'Determined by d i f f e r e n c e . 
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CHAPTER I I I 
DISCUSSION OF RESULTS 
The purpose of this research was to continue the study of the 
biosynthesis of the ant ib io t ic viomycin by Streptomyoes griseus var. 
purpurea. Viomycin is a peptide that y ie lds upon acid hydrolysis the 
three unusual amino acids, L-a,8-diaminopropionic acid, L-8- lys ine , and 
a guanidino amino acid named viomycidine, in addition to the more common 
compounds L-ser ine , ammonia, and carbon dioxide. The major area of 
invest igation of this research was the study of the biosynthesis of each 
of these unusual amino acids, with special attention to the viomycidine 
component. Also investigated during this research was some further 
aspects of the chemical behavior of viomycin. 
The Chemistry of Viomycin 
13 20 
I n f o r m a t i o n p r e s e n t e d in the r e c e n t l i t e r a t u r e ' suggested 
that ca ta ly t ic hydrogenation of viomycin be studied. I t was reported 
that ca ta ly t ic hydrogenation of viomycin under undefined conditions gave 
urea and a perhydro der iva t ive of viomycin that possessed no uv chromo­
phore. Upon acid hydrolysis of this perhydro d e r i v a t i v e , L-ser ine , L-ct,3-
diaminopropionic ac id , L-3- lys ine , capreomycidine, and alanine were pro­
duced in a molar r a t i o of 2:1:1:1:1. The alanine isola ted was found to 
be op t ica l ly ac t i ve , and this opt ica l a c t i v i t y was attributed to s tereo-
spec i f ic hydrogenation. Since the method for determining the molar 
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ra t io was not reported, i t seemed possible that the r a t i o might not be 
accurate. I t also seemed unlikely that op t ica l ly act ive alanine would 
be produced under the hydrogenation conditions used, and i t therefore 
seemed advisable to repeat this experiment. 
I t was found that viomycin was ca t a ly t i ca l ly hydrogenated in 50 
per cent aqueous acetic acid solvent using a 10 per cent platinum on 
carbon catalyst at room temperature and atmospheric pressure. For a 
f i v e to seven gram sample of viomycin sul fa te , the time required for 
complete hydrogenation was usually 400 hr or more. 
From three separate hydrogenation experiments, an average of 
2.64 mmole o f hydrogen (STP) was absorbed per millimole of commercial 
viomycin sulfa te . As mentioned previously, however, commercial viomycin 
sulfate contains some inorganic s a l t s , which serve as buffering agents 
in aqueous solution, as wel l as some water of hydration that i s not 
completely removed under the conditions used to dry the viomycin sample 
prior to hydrogenation. I f 10 per cent is deducted from the weight of 
each viomycin sample to account for these impurit ies, an average of 2.94 
mmole of hydrogen (STP) was absorbed per millimole of viomycin sulfa te . 
During the course of the biosynthetic studies of viomycin, 25 
different samples of viomycin were produced using the usual commercial 
preparation procedure. An average purity of 84.3 per cent was obtained 
for these samples of viomycin sul fa te , as determined by the analyt ical 
21 
methods mentioned previously. Thus, an allowance of 10 per cent for 
impurities is not unreasonable. 
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Although the reaction s i tes of the three equivalents of hydrogen 
are not known with any certainty, the experimental results may be at 
least pa r t i a l ly explained using the structure of viomycin (9_) proposed 
by Johnson. 
9 
One equivalent of the hydrogen was proposed to be consumed in a 
hydrogenolysis of the hydroxyl group in the viomycidine precursor (shown 
as par t ia l structure 9a) to give par t ia l structure 9b. Acid hydrolysis 
of 9b_ would give the related compound capreomycidine ( 1 4 ) , which was 
20 
reported as a hydrolysis product of perhydroviomycin. 
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A second equivalent of hydrogen would be consumed by reduction 
of the o le f in in structure 9 (as shown by par t ia l structure 9c) to g ive 
par t ia l structure 9d, while the third equivalent of hydrogen was 
proposed to be consumed in the hydrogenolytic cleavage of urea from _9d 
to give 9e_. Upon acid hydrolysis , 9e_ would give alanine. Johnson sup­
ported this proposal by synthesizing a model compound (16) that was 
reported to give alanine in good y i e l d upon ca ta ly t ic hydrogenation, 
followed by acid hydrolysis . Oxidation with potassium permanganate 
53 
was reported to give formylurea. Similar results had previously been 
reported by Johnson for viomycin and capreomycin. 
20 
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The alanine isolated was reported to be opt ica l ly act ive 
24 25 (L~a]D - 4 .7° , c , 0.3 in water; l i t . value for ^-alanine, [A] - 1.8°, 
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a, 2 in water ) , and the opt ical a c t i v i t y was attributed to a s tereo-
spec i f ic hydrogenation. 
Since the method of determining the molar r a t io of the hydrolysis 
products of perhydroviomycin was not reported by Johnson, some doubt 
existed as to the accuracy of his resul ts . I t is possible that the ala­
nine produced might be the result of a hydrogenolysis of the C-3 hydroxy1 
of a serine residue. Thus, the serine:alanine ra t io would be expected 
to be more nearly 1:1. In view of these possible discrepancies, i t 
seemed advisable to repeat Johnson's work. 
Somewhat different results were obtained in attempts to repeat 
this work. The product of hydrogenation of viomycin sulfate was shown 
to be a ninhydrin posi t ive material that had no u l t r av io le t chromophore. 
Sephadex chromatography of the crude hydrogenation product showed that 
i t was 9 3 per cent homogeneous. Nessler 's and p-dimethylaminobenzalde-
hyde tests revealed that no ammonium ion or urea was present in the 
crude hydrogenation product. Acid hydrolysis of this material gave 
ser ine, alanine, ammonium chloride, diaminopropionic acid, 3- lysine, 
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and capreomycidine (but no urea) , as wel l as some minor peptides. The 
serine to alanine ra t io was found to be 2:1. 
The fact that no urea was found in the crude perhydroviomycin 
preparation or in the acid hydrolysate of perhydroviomycin is further 
evidence that "old viomycin" and "new viomycin" are in fact different 
ant ibiot ics chemically. Simple removal of the carbamoyl group from 
structure 9 would result in a vinylamine system, which is known to be 
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hydrolyzed very rapidly in aqueous solution. Thus, "new" and "old" 
viomycin may d i f f e r by more than just a urea residue. 
The serine to alanine ra t io demonstrates with reasonable cer­
tainty that alanine is not derived from serine by hydrogenolysis of the 
C-3 hydroxyl of serine. Since alanine is not found in the acid hydrol­
ysate of viomycin, i t is possible that the alanine is derived from the 
chromophore in viomycin or from a nonchromophoric pre-alanine unit by 
reduction with hydrogen. Under the hydrogenation conditions used, how­
ever , i t seems unlikely that such a reaction would be s tereospecif ic 
20 
a n d r e s u l t m op t ica l ly a c t i v e a l a n i n e , as reported by Johnson. 
Optically inactive a l a n i n e was isolated from three separate experiments 
that were designed to repeat Johnson's work. This result i s more con­
sistent with the usual nonstereospecific course followed by most hydro-
genations. This fact also confirms that the alanine is not derived from 
serine by hydrogenolysis, since alanine produced in this manner would be 
expected to be op t ica l ly ac t ive . 
Several other inconsistencies in Johnson's structure for viomycin 
(9_) are apparent. He suggests that 9c is responsible for the uv 
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chromophore of viomycin, and that the shif t in the uv in alkaline solu­
tion is due to a "phenol" shift of the chromophore to g ive a resonance 
s tab i l ized anion such as 9f. To support this proposal, Johnson 
9 c 9 f 
synthesized a model compound (16) and reported that this compound under-
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goes such a shif t in the uv upon addition of a l k a l i . This compound 
was also reported to have a pK^ value of 12.6 in water; this was c i ted 
as evidence that the model c losely resembles viomycin, which has pK 
a 
values of 8.3, 10.3, and 12.2 in water. 
Johnson, however, does not take into account the greater 
bas ic i ty of the guanidine group in the viomycidine precursor 9a_, which 
would more l i k e l y be responsible for the pK^ value of 12.2 in viomycin. 
In addit ion, the fact that both "old viomycin" (which contains a urea 
residue) and "new viomycin" (which does not contain urea) have the same 
pK a values, as we l l as the same uv absorption, indicates that Johnson's 
structure for viomycin (9_) i s not correct . 
Perhaps a bet ter structure for the uv chromophoric center would 
be as shown in part structure 17. This structure could be expected to 
y i e l d viomycidine ( 4 ) under conditions of acid hydrolysis . Catalyt ic 
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17 
hydrogenation, followed by acid hydrolysis , would also be expected to 
give capreomycidine, as observed experimentally. Although Johnson 
reported that his model compound (16_) has a one proton s ingle t at x 2.2 
in the nmr spectrum (hexadeuteriodimethylsulfoxide-deuterium oxide 
5 3 
s o l v e n t ) , the o l e f in i c proton of 17 that is adjacent to the guanidino 
function is in a very electronegative environment and would be expected 
to be strongly deshielded and thus would appear at very low f i e l d . The 
guanidino group could easi ly account for the pK value of 12.2 in v i o -
mycin, and the extended system of electron density would be expected to 
absorb strongly in the uv, which should shif t in alkaline solution due 
to deprotonization of the guanidino function. 
the available data, i t is clear that structure 9 is incorrect . The 
data at hand, however, are not suff ic ient to allow the proposal of a 
more suitable structure. 
I t i s interesting to note that although hydrogenation of viomycin 
destroys the uv chromophore completely, b io log i ca l a c t i v i t y is retained 
to the extent of 30 per cent by perhydroviomycin. In a l l other cases of 
In view of the many inconsistencies of Johnson's structure with 
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chemical al terat ion of viomycin, destruction of the uv chromophore was 
accompanied by loss of b io log ica l a c t i v i t y . These facts and a complete 
description of perhydroviomycin and the related perhydrocapreomycin have 
been reported to the of f ices of s c i e n t i f i c research at the Georgia 
Inst i tute of Technology and the National Insti tutes of Health. Record 
, 55 
of Invention and Disclosure of Invention forms have also been f i l e d . 
The Biosynthetic Studies of Viomycin 
The proposed method of invest igat ion of the biosynthesis of 
14 
viomycin was to produce viomycin in the presence of C-labeled com­
pounds suspected of being precursors of one or more of the fragments of 
viomycin. The methods used for production of viomycin were similar in 
every respect to those used in ea r l i e r biosynthetic studies of viomy-
6 14 21 14 
c m . ' ' The C-labeled viomycin was hydrolyzed; the individual 
hydrolysis components were separated, and the ac t i v i t y of each component 
was determined as previously described.^ Further degradation was 
planned for any of the hydrolysis components found to contain s i g n i f i ­
cant rad ioac t iv i ty in order to determine the complete labeling pattern 
for those compounds. Seven radioact ively labeled compounds suspected 
of being precursors of viomycin were investigated with respect to thei r 
incorporation into viomycin. 
Of major interest in this study was the biosynthetic or ig in of 
. . 14 
the viomycidine component m viomycin. Z?L-Arginine-amidine- C, DL-
14 . 14 
orni thme-1- C, and DL-arginine-1- C were chosen as possible viomy­
cidine precursors. The resulting radioact ively labeled viomycin samples 
were hydrolyzed; the individual hydrolysis components were separated. 
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Plots of the a c t i v i t i e s versus fraction number are shown in Figures 2, 
3, and 4. The fractions containing the largest amounts of a c t i v i t y 
were ident i f ied by ninhydrin tests and by comparison of the data from 
previous experiments. The fractions combined, their i d e n t i t i e s , 
weights, and the to t a l a c t i v i t i e s of the hydrolysis components are 
shown in Table 5. 
Qual i ta t ive ly , a l l three of these ac t iv i ty plots are similar in 
appearance, showing that each of the three precursors is incorporated 
into each of the hydrolysis components to approximately the same extent. 
A l l three precursors were incorporated primarily into isoviomycidine and 
viomycidine, as wel l as some of the more basic peptides. A to t a l of 
52.1 per cent of the to ta l a c t i v i t y recovered from the Dowex 50 column 
was found in the isoviomycidine and viomycidine fractions originating 
14 14 from arginine-amidine- C precursor. When ornithine-1- C and arginine-
14 
1- C were used as precursors, 59.6 per cent and 77.2 per cent of the 
a c t i v i t i e s , respec t ive ly , were found in the isoviomycidine and viomyci­
dine fract ions. 
14 
In addition to these three compounds, Z?L-arginine-5- C was also 
used as a precursor in a previous experiment. 6 Again, s ignif icant 
a c t i v i t y appeared only in the isoviomycidine, viomycidine, and basic 
peptides fract ions. Since these basic peptides are s ign i f ican t ly 
labeled only in those experiments in which viomycidine is s ign i f ican t ly 
labeled, these peptides apparently contain fragments derived from the 
viomycidine precursor. 
The fact that the three spec i f i ca l ly labeled arginine precursors 
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and the ornithine precursor are each incorporated into viomycidine to a 
large extent is evidence that these compounds are direct precursors of 
viomycidine. This does not necessarily rule out that the X-amidino-
38 
transferase system proposed by Pas's* and coworkers is operating in v i o ­
mycin biosynthesis, but i t does seem to indicate that the system is of 
only minor importance, i f i t is operative at a l l . 
guanidino amino acids and that their molecular formulas d i f f e r by only 
four hydrogen atoms. The relationship between the structure of arginine 
A 
(12) and that of viomycidine is shown in Equation 2. 
primarily into viomycidine, i t was necessary to devise a suitable 
degradation scheme for viomycidine in order to determine whether the 
labeling pattern of the viomycidine was consistent with the labeling 
pattern of the precursor. Information obtained from such a study would 
indicate whether or not each precursor was incorporated spec i f i ca l ly as 
the carbon skeleton of viomycidine. 
I t is interest ing to note that both arginine and viomycidine are 
Since the ornithine and arginine precursors were incorporated 
The f i r s t structure proposed for viomycidine was 2-guanidino-A -
pyrroline-5-carboxylic acid, 18. 56 The major evidence supporting this 
'2' 
18 
P. 16, this thesis . 
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structure was the fact that acetyla t ion, followed by ozonolysis (hydro­
gen peroxide workup), and acid hydrolysis of the result ing material gave 
A 
aspartic acid and guanidine. 
Viomycidine was treated with acet ic anhydride and dry pyridine at 
steam bath temperatures for 8 to 20 hr. No attempt was made to i so la te 
the acetylated viomycidine from the dark brown reaction mixture. In­
stead, the acetylated material was ozonized in 80 per cent formic acid 
at 0° for one hour. A 30 per cent solution of hydrogen peroxide was 
added to the ozonized solut ion, and the resulting mixture was allowed 
to stand at room temperature overnight. Acid hydrolysis of this mate­
r i a l using 6 N hydrochloric acid and steam bath temperatures gave a 
mixture of DL-aspartic acid and guanidine in 52 per cent y i e l d ; traces 
of viomycidine and some other unidentified components were detected. 
The fact that DL- rather than D- or L-aspartic acid was obtained was 
attributed to racemization of the asymmetric center by pyridine during 
the acetyla t ion . 
Although no attempt was made to i so la te an acetylated viomycidine 
from the pyridine-acet ic anhydride reaction mixture, the compounds ob­
tained from ozonolysis , followed by acid hydrolysis , suggest that the 
material present in the acetylat ion solution has the structure 19. 
Ozonolysis, followed by acid hydrolysis , would be expected to g ive 
guanidine from the guanidino group, aspartic acid from C - l , 2, 3, and 
* . 57 
Mi l le r prepared an acetyl der ivat ive of viomycidine using 
acet ic anhydride in ethanol-water solvent that was inert to ozonolysis . 
Acid hydrolysis of this der iva t ive following ozonolysis gave only v i o ­
mycidine and no s ignif icant degradation products. 
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4, and carbon dioxide from C-5. The acetyl group would be converted 
to acet ic acid in the acid hydrolysis . 
A possible mechanism for the formation of 19_ in hot pyridine-
acet ic anhydride solution is shown in Scheme 1. 
The pyridine-acetic anhydride reaction sequence allows viomy­
cidine to be degraded into individual compounds which, after separation 
of the hydrolysis components, contain only C-6, C-5, or C - l , 2, 3, and 
4. The guanidine (C-6) and carbon dioxide (C-5) produced can be counted 
d i r ec t ly . The aspartic acid produced from C- l , 2, 3, and 4 can be ox i ­
dized with ninhydrin to separate C-l from C-2, 3, and 4. Thus, the 
a c t i v i t i e s at C - l , C-2, 3, 4, C-5, and C-6 can be determined indi­
v idual ly . 
The degradations of the viomycidine samples from viomycin derived 
14 14 14 from arginme-amidine- C, ornithine-1- C, arginine-1- C, and arginine-
S-^C were carried out using the method developed by Nassar."*"6 After 
the acetylation and ozonolysis (hydrogen peroxide workup) react ions, the 
solution was hydrolyzed using 6 N hydrochloric acid. The dark brown 
hydrolysate was decolorized with Darco G-60 and, af ter removal of the 
See footnote ( p . 54, this thes i s ) for an explanation of the 
numbering system used. 
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carbon, was evaporated to a syrupy, c rys ta l l ine mass. This material was 
chromatographed using Whatman Number 17 preparative chromatographic 
paper and a 95 per cent ethanol:3 N ammonium hydroxide ( 5 : 1 ) solvent 
system. Only the centers of the aspartic acid and guanidine bands were 
cut from the paper strips in order to obtain the purest possible mate­
r i a l s . This method separated the guanidine and aspartic acid components 
from each other and from most of the trace components very e f f i c i e n t l y . 
Each sample was concentrated and diluted to exactly 3.00 ml with water 
for counting and further degradation studies. 
Several problems are inherent in this degradation and separation 
scheme. None of the degradative reactions is quantitative in y i e l d . A 
considerable amount of unchanged viomycidine remains in the degradation 
sample, and at least two other unidentified reaction products revealed 
by paper chromatography were present. Thus, the a c t i v i t i e s usually re­
covered in the aspartic acid, guanidine, and carbon dioxide (from C - 5 ) 
are only a part of the to ta l starting ac t i v i t y of each of the viomyci­
d i n e s a m p l e s . I n a d d i t i o n , some overlapping o f b a n d s d o e s o c c u r on t h e 
paper chromatograms, and even select ion of just the band centers does 
not avoid this problem completely. Of more importance is the fact that 
hot water elution of the guanidine and aspartic acid from the paper 
s tr ips also y ie lds r e l a t i v e l y sizable quantities of soluble polysaccha­
r ides . Since the amounts of guanidine and aspartic acid separated by 
this method were usually small (5 to 20 mg), these water soluble sac­
charides presented a s ignif icant purity problem. No successful method 
of removing these impurities was found, and the impure guanidine and 
aspartic acid isolated were used without further treatment. 
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For these reasons, i t was not possible to obtain accurate values 
for the spec i f ic a c t i v i t i e s of the guanidine and aspartic acid samples. 
Thus, no accurate comparison between the spec i f ic a c t i v i t i e s of the 
viomycidine samples and the samples of the degradation components could 
be made. I t is interesting to note, however, that the a c t i v i t i e s i so ­
lated from each degradation were generally a constant fraction of the 
to ta l starting a c t i v i t y . This indicates that the entire degradation 
and separation scheme resulted in approximately the same y i e l d for each 
viomycidine sample. 
These problems were at least pa r t i a l ly overcome in the two 
14 . 14 
experiments involving the orni thme-1- C and arginine-1- C precur­
sors. A 250 u l aliquot of a 3 . 0 0 ml solution of the aspartic acid 
derived from the viomycidine degradation was counted in the usual way. 
A second 250 u l aliquot of the aspartic acid solution was subjected to 
ninhydrin oxidation. The ac t i v i t y contained in the f i r s t 250 u l a l i ­
quot was also recovered in the ninhydrin oxidation sample, ei ther in 
t h e c a r b o n d i o x i d e t r a p p e d f r o m t h e r e a c t i o n , i n t h e r e s i d u a l r e a c t i o n 
mixture, or as the sum of the two. Thus, although accurate comparisons 
between the a c t i v i t i e s of the starting viomycidine samples and the 
guanidine and aspartic acid degradation products could not be made, the 
labeling pattern of the start ing viomycidine could be inferred from the 
r e l a t i ve a c t i v i t i e s obtained for each degradation product. Comparison 
of the r e l a t i ve a c t i v i t i e s of each degradation component was also used 
to assign the labeling pattern to the viomycidine samples derived from 
14_ , . . _ 14 0 
arginme-amidme- C and a r g m m e - 5 - C. 
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The viomycidine derived from the arginine-amidine- C precursor 
was degraded as previously described. No attempt was made to co l lec t 
the carbon dioxide produced that was derived from C-5. The guanidine 
(C-6) isolated was found to contain 1820 dpm per 250 ul aliquot of a 
3.00 ml solution of the crude guanidine i s o l a t e . The aspartic acid 
( C - l , 2 , 3 , 4 ) isolated was found to contain 140 dpm per 250 ul aliquot 
of a similar solution of the aspartic acid i s o l a t e . Thus, approximately 
92 per cent of the to t a l a c t i v i t y isolated from the degradation scheme 
was found in the guanidine, while approximately 8 per cent of the 
ac t i v i t y was found in the aspartic acid. The aspartic acid sample was 
not degraded further. 
14 
Low leve l s of C ac t i v i t y were found in almost a l l of the com­
ponents isolated from this degradation scheme. As described previously, 
some overlapping of bands occurred in the paper chromatographic separa­
tion and. thus, i so la t ion of pure guanidine or pure aspartic acid was 
impossible. I t i s be l ieved , therefore , that small a c t i v i t i e s found in 
samples such as the 8 per cent found in this aspartic acid sample result 
14 
from C-labeled impurities and not necessarily from labeling in the 
aspartic acid i t s e l f . 
These results indicate that the guanidino group of the arginine 
precursor i s incorporated into viomycidine without s ignif icant change. 
Since only a very small amount of the t o t a l a c t i v i t y isolated was found 
in the aspartic acid, the guanidine carbon is not appreciably scrambled 
with the other carbon atoms in viomycidine. 
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The viomycidine derived from the ornithine-1- C precursor was 
degraded and again, no attempt was made to co l lec t the carbon dioxide 
from the C-5 carbon. The guanidine isolated was found to contain 113 
dpm per 250 u l a l iquot , or 3.1 per cent of the t o t a l a c t i v i t y . The 
aspartic acid was found to contain 3515 dpm per 250 u l a l iquot , or 97.0 
per cent of the a c t i v i t y . Ninhydrin oxidation of this aspartic acid 
sample was carried out in duplicate. An average of 1794 dpm per 250 
Ul aliquot of the aspartic acid was found at C-l (48.6 per cent of the 
a c t i v i t y ) , while the residual ninhydrin oxidation reaction solution was 
found to contain 1788 dpm per 250 u l aliquot of the aspartic acid (48.4 
per cent of the a c t i v i t y ) . 
These results were rather surprising, since i t was anticipated 
14 
that ormthine-1- C would be incorporated spec i f i c a l l y into viomyci­
dine, such that only the carboxyl carbon of viomycidine (and thus the 
C-l carbon of aspartic ac id) would be s ign i f ican t ly labeled. A small 
14 
sample of the or ig ina l ornithine-1- C precursor was subjected to nin­
hydrin oxidation in order to determine whether or not the ornithine was 
in fact spec i f i ca l ly labeled at C- l . 
14 
Duplicate samples of the DL-ornithme-1- C used as the precur­
sor for viomycin biosynthesis were degraded in the same manner as the 
aspartic acid. Counting of both the carbon dioxide produced and the 
residual reaction solution revealed that an average of 98.2 per cent of 
14 
the C a c t i v i t y was located at C-l in the ornithine sample. 
Due to the experimental d i f f i c u l t i e s previously described, i t i s 
impossible to interpret the data from this experiment conclusively. I t 
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is possible that the chromatographic separation of the aspartic acid 
produced in the viomycidine degradation was not complete, and that some 
14 
C-labeled material that i s not degraded by the ninhydrin oxidation 
reaction was present in the aspartic acid sample. Thus, the a c t i v i t y 
derived from the C-l carbon of aspartic acid would be found in the 
carbon dioxide trapped, while the nondegradable material would remain 
in the reaction f lask. I t i s probably coincidental that the numerical 
values for the a c t i v i t i e s were very nearly the same. 
A second and more probable explanation is that the label of the 
14 
orni thme-1- C i s simply scrambled by some unknown biochemical pathway 
to give labeling at C-2, 3, and/or 4 of the aspartic acid result ing from 
degradation of viomycidine. Such a poss ib i l i t y is supported by the fact 
that a l l four of the degradation experiments were carried out in ident i ­
cal fashion and that both the aspartic acid derived from the arginine-1-
14 14 
C and that derived from the orni thme-1- C were degraded simultane­
ously and in exactly the same manner. I t seems unlikely that an experi­
mental inaccuracy of 50 per cent would occur under these conditions in 
only one of the cases. In addition, the a c t i v i t i e s fo r both aspartic 
acid samples were in good agreement with the starting a c t i v i t i e s of 
their respective viomycidine samples. 
Since the results from this experiment are not conclusive, i t i s 
highly recommended that this experiment be repeated in a subsequent 
study on viomycin biosynthesis. Incorporation of other spec i f i ca l l y 
labeled ornithine precursors should also be t r i ed in order to c l a r i f y 
the biochemical fate of ornithine in viomycin biosynthesis. 
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The viomycidine derived from the arginine-!- C precursor was 
degraded; no attempt was made to co l l ec t the carbon dioxide from the C-5 
carbon. The guanidine isolated was found to contain only 5.2 per cent 
of the to t a l a c t i v i t y . The aspartic acid isolated was found to contain 
94.8 per cent of the a c t i v i t y , of which 91.4 per cent of the t o t a l 
a c t i v i t y was at C-l and 3.4 per cent was at C-2, 3, and 4. 
These results suggest that the carbon skeleton of arginine i s 
incorporated into viomycidine in viomycin biosynthesis. At least the 
carboxyl carbon of the arginine is incorporated as the carboxyl carbon 
of viomycidine with l i t t l e or no scrambling. 
I t i s interesting to note that i f the X-amidinotransferase system 
14 
proposed by Pas's* and coworkers were operat ive , the arginine-1- C would 
14 • . . 
be converted into an amidine group and ornithine-1- C. The amidine 
group may we l l be incorporated into viomycidine d i r e c t l y , but based on 
14 
the results of the previous orni thine-1- C experiment, the label ing 
pattern of the ornithine would be expected to be scrambled before in­
corporation into viomycidine. Such is not the case, since arginine-1-
14 
C undergoes no scrambling upon incorporation into viomycidine. Thus, 
i t i s probable that the X-amidinotransferase system is inoperative in 
viomycin biosynthesis, and that arginine is incorporated d i r ec t ly into 
viomycidine. 
14 
I t was anticipated that the majority of the C a c t i v i t y in the 
14 
viomycidine derived from arginine-5- C would be in the C-5 carbon of 
the viomycidine skeleton. This carbon is los t as carbon dioxide during 
the ozonolysis , workup, and acid hydrolysis steps of the degradation 
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scheme. Attempts were made to co l l ec t this carbon dioxide as the car­
bonate sal t of Hyamine hydroxide and to count i t d i r ec t ly . Although a 
to t a l of 2.04 x i o 5 dpm of this a c t i v i t y was co l l ec ted , this was only a 
small portion of the to ta l starting a c t i v i t y . 
Several experimental problems made the task of co l lec t ing the 
carbon dioxide quanti tat ively very d i f f i c u l t . The ozonolysis reaction 
apparatus was set up in such a way that the effluent gases from the 
ozonolysis mixture were bubbled through a 0 ° , l iquid styrene trap, 
which removed a l l traces of residual ozone, and then into a trap con­
taining Hyamine hydroxide. The gas flow that was necessary for complete 
ozonolysis of the acetylated viomycidine was much too rapid for the 
Hyamine hydroxide to e f f e c t i v e l y trap a l l of the carbon dioxide pro-
14 
duced. I t i s possible that much of the C-labeled carbon dioxide was 
los t in this step. 
After ozonolysis , 5.0 ml of a 30 per cent solution of hydrogen 
peroxide was added to the ozonolysis solution in this closed reaction 
system through a rubber serum cap. The system was allowed to stand at 
room temperature overnight. After this time, 5.0 ml of additional 
hydrogen peroxide was added, and a very slow purge of oxygen was allowed 
to flow through the reaction system in order to co l l ec t any carbon 
dioxide produced in the workup. The Hyamine hydroxide trap, which was 
used for both steps, was diluted to 50.0 ml with methanol, and a 250 ul 
aliquot was counted as usual. A to t a l of 8.7 x i o dpm was col lected 
from these reactions. 
The reaction solution was removed from the ozonolysis system and 
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was evaporated to a syrup. No attempt was made to co l lec t any carbon 
dioxide released during this evaporation due to the d i f f i c u l t i e s in­
volved. The syrup was hydrolyzed using 6 N hydrochloric acid as usual. 
A slow nitrogen purge was bubbled through the hydrolysate and into a 
second Hyamine hydroxide trap. The contents of the trap were diluted 
5 
and counted as before. A to t a l of 1.2 x 10 dpm was col lec ted from the 
acid hydrolysis reaction. 
The aspartic acid isolated from the acid hydrolysate had an 
a c t i v i t y of 170 dpm per 250 ul aliquot and the guanidine isolated had 
an a c t i v i t y of 13 dpm per 250 ul a l iquot . Although these a c t i v i t i e s 
are not d i rec t ly comparable to the ac t i v i t y of the carbon dioxide c o l ­
l ec ted , i t i s readily apparent that far less than 1 per cent of the 
t o t a l a c t i v i t y i s located at C - l , 2, 3, 4, and 6. 
From these data, i t is apparent that the C-5 carbon in the 
arginine skeleton is incorporated into the C-5 carbon of the viomycidine 
skeleton with almost no scrambling. 
14 
ALTHOUGH the RESULTS of the orni thme-1- C experiment are not 
conclusive, the results of the three arginine experiments strongly sug­
gest that arginine, at l eas t , i s incorporated d i rec t ly into the viomy­
cidine unit in the viomycin molecule. No al terat ion of the carbon 
skeleton of the arginine is evident in any case. I t i s recommended that 
future studies on these biosynthetic pathways should include experiments 
using several labeled ornithine and c i t ru l l i ne precursors, as wel l as 
other metabolic products of arginine. 
Since the reaction pathways for viomycin biosynthesis were 
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unknown, i t was important to devise experiments that would indicate the 
overa l l route of the biosynthesis of viomycin. At least two reaction 
pathways were considered: 1) that a polypeptide chain of normal amino 
acids was constructed and then modified biosynthet ical ly to g ive the 
unusual amino acid residues, or 2) that the unusual amino acids were 
biosynthesized f i r s t and then incorporated into the viomycin polypep­
t ide chain. In order to test these p o s s i b i l i t i e s , i t was necessary to 
14 
attempt to incorporate C-labeled samples of the unusual ammo acids 
a,3-diaminopropionic acid, 3- lysine, and viomycidine d i rec t ly into v i o -
14 
mycin. Thus, i f the f i r s t pathway were operat ive, the C label from 
each precursor would either not be incorporated at a l l , or would be 
distributed among several of the amino acid residues of viomycin. I f 
the second pathway were operat ive, each of the precursors would be 
expected to be incorporated d i rec t ly into the respective residue in 
14 
viomycin with no scrambling of the C label or distr ibution into the 
other amino acids. 
14 
Samples of C-labeled a,3-diaminopropionic acid, 3- lysine, and 
viomycidine are unavailable commercially. Since i t was desirable to 
use these compounds as potential precursors for viomycin biosynthesis, 
14 6 
the glucose-U- C experiment (Run No. 1) carried out by Floyd was 
repeated using a much larger quantity of more highly labeled glucose. 
In this experiment (Run No. 1 8 ) , viomycin was produced in the usual 
manner. The viomycin was hydrolyzed without the addition of unlabeled 
viomycin, and the hydrolysate was chromatographed in the same manner 
as that of the previous experiments. The ac t i v i t y curve for this 
85 
experiment is shown in Figure 5. The four peaks centered at fractions 
162, 304, 321, and 357 were isolated and ident i f ied as serine, diamino­
propionic ac id , 8 - lys ine , and viomycidine, respec t ive ly . A number of 
other unidentified peaks of a c t i v i t y were also found. I t is noteworthy 
that even in this experiment, in which the l eve l s of a c t i v i t y were 
greater than in any other experiment, not a trace of urea was found in 
the hydrolysate of the viomycin. The small peak centered at fraction 
98 gave a negative p-dimethylaminobenzaldehyde t e s t , showing that no 
urea was present. The diaminopropionic acid, 8 - lys ine , and viomycidine 
fractions were separated, lyoph i l i zed , and used for incorporation with­
out further puri f icat ion. 
14 
The C-labeled diaminopropionic acid from Run No. 18 was 
incorporated into viomycin (Run No. 19) . The resulting viomycin was 
hydrolyzed, and the hydrolysate was chromatographed as usual. A plot 
of the a c t i v i t i e s versus fraction number is shown in Figure 6. The 
peak centered at fraction 150 was determined to be serine, and the peak 
at 284 was a,8-diaminopropionic acid. 
Floyd 6 has previously determined that diaminopropionic acid from 
14 
viomycin derived from glucose-U- C was uniformly labeled. The diammo-
. 14 
propionic- C acid from Run No. 19 was also degraded to determine the 
labeling pattern. Ninhydrin oxidation revealed that 27.6 per cent of 
the to t a l a c t i v i t y was located at C- l ; periodate oxidation revealed that 
33.2 per cent of the a c t i v i t y was located at C-3; by dif ference, 39.2 
per cent of the a c t i v i t y was at C-2. These data are shown in Table 6 
and indicate within experimental error that the diaminopropionic acid 
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14 
from viomycin derived from the diaminopropionic-U- C acid precursor is 
also uniformly labeled. 
I t i s noteworthy that while Floyd's studies showed that spe­
c i f i c a l l y labeled serine was converted to diaminopropionic acid to a 
s ignif icant extent, this study showed that the reverse conversion i s 
14 
of only minor importance, since very l i t t l e C-labeled serine was pro-
14 
duced. Neither i s the diaminopropionic-U- C acid apparently converted 
biosynthet ical ly into any of the other hydrolysis products, for no other 
peaks of a c t i v i t y are found in the a c t i v i t y curve (Figure 6 ) . 
14 
The 8- lysme- C from Run No. 18 was also incorporated into 
viomycin (Run No. 20) . A plot of the a c t i v i t i e s versus fraction numbers 
from the hydrolysis and chromatography of this viomycin sample i s shown 
in Figure 7. The peak centered at fraction 400 was pos i t i ve ly ident i ­
f ied as 3- lysine by t i c , paper chromatography, and paper electrophoresis 
(0.2 M formic acid b u f f e r ) . From the ac t i v i t y curve (Figure 7 ) , i t i s 
readi ly apparent that 3- lysine precursor is incorporated only into 3-
lysine in viomycin biosynthesis. An almost t o t a l absence of other 
a c t i v i t y peaks rules out any conversion of 3- lysine into other components 
of viomycin. In this way, 3- lysine was found to be quite d i f ferent b io ­
synthetical ly from lys ine , which was s igni f icant ly converted into serine 
14 6 
and diaminopropionic acid in previous studies using lys ine-2- C and 
l y s m e - 1 - C. 
Although viomycidine does not occur in viomycin, an attempt was 
14 
made to incorporate the viomycidine- C from Run No. 18 into viomycin. 
An a c t i v i t y curve from the hydrolysis and chromatography of this 
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viomycin sample (Run No. 21) is shown in Figure 8. Apparently, the 
viomycin-producing organism cannot use viomycidine very e f f i c i e n t l y 
as a precursor for the synthesis of viomycin since only minor a c t i v i t y 
was found in any fract ion. Thus, this study is further evidence that 
viomycidine does not exis t in viomycin per se3 but i s produced during 
acid hydrolysis of viomycin. 
These studies show very conclusively that viomycin i s biosyn-
thesized by prior formation of the unusual amino acids, followed by 
direct incorporation of these amino acids into the viomycin polypeptide 
chain. The fact that each of these amino acids is incorporated only 
into the respective residue in viomycin suggests that the biosynthetic 
reactions that produce these unusual amino acids are essent ia l ly i r r e ­
ve r s ib le . In addition, each of the unusual amino acids was incorporated 
into viomycin at least to the same extent that other more common pre­
cursors were incorporated. The 8-lysine precursor was incorporated into 
14 
viomycin to a greater extent (8.15%) than any other C-labeled precur­
sor used. 
14 
In addition to the C-labeling experiments, three other experi­
ments using "^N- or deuterium-labeled precursors were carried out. A 
2 
sample of 3,3-dideuterioserine (90% 2 H at C-3) was incorporated into 
viomycin (Run No. 24 ) , and the viomycin produced was hydrolyzed. No 
unlabeled viomycin was added to the labeled sample prior to hydrolysis . 
The hydrolysate was separated into the individual components as usual. 
Low resolution mass spectra were obtained for the serine and diamino­
propionic acid samples from this experiment. The serine samples had an 
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indicated atom excess of 1.32 per cent at M + 1 ( H) and 0.65 per cent 
at M + 2 (2 2 H) for the molecular ion (m/e 60,61,62). The diaminopro­
pionic acid sample was found to have an indicated, atom excess of 6.15 
2 2 
per cent at M + 1 ( H) and 1.78 per cent at M + 2 (2 H) for the molecu­
lar ion (m/e 59,60,61). 
These results indicate that both the serine and diaminopro­
pionic acid samples have two deuterium atoms per molecule, as did the 
o r ig ina l precursor. This would indicate that serine is aminated 
d i r ec t ly to produce diaminopropionic acid , rather than oxidized to the 
29* 
semialdehyde and transaminated as proposed by Reinbothe. 
Lys ine - 1 5 N (Run No. 22) was also studied in order to determine 
whether or not the nitrogens are incorporated d i rec t ly into the other 
amino acids without the intervention of free ammonia. The l y s i n e - ^ N 
(95 atom per cent 1 5 N in both posi t ions) was incorporated into viomycin. 
After hydrolysis and separation of the hydrolysate, the ser ine, diamino­
propionic acid, and 3-lysine produced were analyzed by low resolution 
mass spectrometry. The serine derived from lysine-"^N showed a 1.66 per 
cent atom excess at M + 1 (m/e 61) , which indicates that one of the 
nitrogens of lysine i s incorporated d i rec t ly into serine. Based on 
14 
previous C-labeling experiments, i t i s quite evident that the carbon 
skeleton of lysine i s also incorporated d i r ec t ly into serine. Thus, i t 
would appear that C - l , 2, and possibly C-3 of lysine are converted into 
serine, without loss of the C-2 amino group. 
15 
The diaminopropionic acid derived from the lys ine - N i s probably 
* 
See Equation 1, p. 13 this thes is . 
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produced in a similar manner, since 0.97 per cent atom excess was found 
at C-2 of diaminopropionic acid, and 0.85 per cent was found at C-3. 
These results indicate that both nitrogens of diaminopropionic acid are 
labeled to approximately the same extent. 
Although the data obtained from these low resolution mass spec­
tra may not be precise , i t i s believed that at least a good indication 
of the labeling pattern can be obtained. High resolution mass spectra 
are being obtained; these w i l l g ive a much more accurate indication of 
the label ing pattern of these samples. 
Although no mass spectral data on 8- lysine has been reported in 
the l i t e r a tu r e , the fragmentation pattern was found to be analogous to 
58 59 
that of lys ine . ' Two peaks in the 8- lysine spectrum were studied; 
+ 
the peak at m/e 56 corresponds to H2N=CHCH=CH2, which represents only 
the nitrogen contained in the e-amino group of 8 - lys ine . The peak at 
NH9 
I + 
m/e 101 represents the diamine ion H2N-CH2CH2CH2CHCH2, which includes 
both the 8- and e-amino groups. Thus, the atom excess at the 8-posit ion 
was indicated by the difference in the atom excess at m/e 103 and m/e 
57. 
15 
The 8- lysine derived from lys ine - N was found to be labeled in 
both the 8- and the e-posit ions. I t appears, therefore , that the amino 
groups of lysine that are incorporated into 8- lysine are not converted 
14 
to ammonia. In conjunction with the C-labelmg resu l t s , i t i s clear 
that lysine i s incorporated d i r ec t ly into 8- lysine without pr ior metabo­
lism. These results are in agreement with those reported by Barker and 
34 35 
coworkers and by Stadtman and coworkers. 
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Serine- N was also used as a precursor for viomycin biosynthe­
sis (Run No. 23) . The viomycin produced was hydrolyzed, and the 
hydrolysate was separated as usual. Low resolution mass spectra were 
obtained for the serine, diaminopropionic acid, and 8-lysine samples 
from this experiment. As anticipated, both serine and diaminopropionic 
acid were labeled; however, the diaminopropionic acid appeared to be 
labeled approximately equally at both the a- and 8-positions. This 
would suggest that diaminopropionic acid is produced from serine by 
direct amination involving a second molecule of serine as the nitrogen 
donor. Intervention of free ammonia would be expected to result in 
l i t t l e or no labeling at the 8-position and thus, direct amination 
involving free ammonia could not account for the observed resul ts . 
The 8-lysine derived from this experiment was found to be 
labeled almost exclusively at the 3-position. These data are in agree-
14 
ment with the C-labelmg experiments and indicate that serine is a 
precursor of 3-lysine. 
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CHAPTER I V 
C O N C L U S I O N S AND RECOMMENDATIONS 
V i o m y c i n c a n b e c a t a l y t i c a l l y h y d r o g e n a t e d t o g i v e a h o m o g e n e o u s 
p e r h y d r o p r o d u c t t h a t d i f f e r s f r o m t h e p a r e n t v i o m y c i n i n a m i n o a c i d 
c o m p o s i t i o n . T h e p e r h y d r o v i o m y c i n h a s n o u v c h r o m o p h o r e , b u t i s 
b i o l o g i c a l l y a c t i v e . T h e d a t a f r o m t h e s e e x p e r i m e n t s w e r e u s e d t o 
i n v a l i d a t e t h e s t r u c t u r e s p r e v i o u s l y p r o p o s e d f o r v i o m y c i n . I t i s 
r e c o m m e n d e d t h a t f u r t h e r s t r u c t u r a l s t u d i e s o f v i o m y c i n b e p u r s u e d , 
e s p e c i a l l y i n t h e d i r e c t i o n o f a s i n g l e c r y s t a l X - r a y a n a l y s i s o f a 
s u i t a b l e d e r i v a t i v e o f v i o m y c i n . I t i s a l s o r e c o m m e n d e d t h a t f u r t h e r 
s t u d y o f t h e p e r h y d r o v i o m y c i n b e p u r s u e d i n l i g h t o f t h e b i o l o g i c a l 
a c t i v i t y t h a t t h i s m a t e r i a l d e m o n s t r a t e d . 
S e v e n r a d i o a c t i v e l y l a b e l e d c o m p o u n d s w e r e s t u d i e d a s p o s s i b l e 
14 
p r e c u r s o r s f o r v i o m y c i n b i o s y n t h e s i s . A r g m i n e - a m i d m e - C , o r n i t h i n e -
14 . . 14 14 
1 - C , a r g i n m e - 1 - C , a n d a r g i n i n e - 5 - C w e r e f o u n d t o b e i n c o r p o r a t e d 
m o s t l y i n t o t h e v i o m y c i d i n e u n i t o f v i o m y c i n . D e g r a d a t i o n o f e a c h 
v i o m y c i d i n e s a m p l e d e r i v e d f r o m e a c h o f t h e s e p r e c u r s o r s r e v e a l e d 
t h a t e a c h v i o m y c i d i n e s a m p l e r e t a i n e d t h e same l a b e l i n g p a t t e r n a s t h e 
14 
r e s p e c t i v e a r g i n i n e p r e c u r s o r , b u t t h e l a b e l f r o m t h e o r n i t h m e - 1 - C 
p r e c u r s o r a p p e a r e d t o b e s c r a m b l e d . 
14 14 
a , 8 - D i a m i n o p r o p i o n i c - U - C a n d 8 - l y s i n e - C ( l a b e l i n g p a t t e r n 
u n d e t e r m i n e d ) w e r e a l s o s t u d i e d a s p o t e n t i a l p r e c u r s o r s f o r v i o m y c i n 
b i o s y n t h e s i s , a n d b o t h w e r e f o u n d t o b e i n c o r p o r a t e d o n l y i n t o t h e i r 
92 
respective residues in viomycin. Thus, no conversion of ei ther compound 
occurs in S. griseus that would result in labeling in any of the other 
14 
amino acids of viomycin. Viomycidine- C was not incorporated into any 
component of viomycin to a s ignif icant extent. 
15 15 
Lysine- N, serine- N, and 3,3-dideuterioserine were a l l found 
15 
to be incorporated into viomycin. From the lys ine- N, both nitrogen 
atoms of 3-lysine and diaminopropionic acid and the nitrogen atom of 
serine were found to be s igni f icant ly labeled. Thus, lysine would seem 
to be converted d i r ec t ly into 3-lysine without intermediate conversion 
of the amino nitrogen atoms into free ammonia. The dual label ing of the 
diaminopropionic acid would appear to indicate that this compound is 
produced biosynthet ical ly from a serine residue by di rect amination 
15 
involving a second serine molecule. The N-labeling in serine i s in 
agreement with at least one known pathway of lysine to serine conver­
sion. 
The serine and diaminopropionic acid derived from the 3,3-
dideuterioserine were both found to contain two deuterium atoms per 
molecule. This indicates that in the serine to diaminopropionic acid 
conversion, the C-3 carbon of serine i s not converted to an aldehyde 
and then aminated, but i s apparently aminated by d i rec t displacement, 
such that neither of the deuterium atoms i s displaced. 
14 
I t i s strongly recommended that the orni thme-1- C labeling 
experiment be repeated. The results from this experiment were somewhat 
inconclusive, and c l a r i f i c a t i on of the biosynthetic incorporation of 
ornithine into viomycin in S. griseus i s necessary. Other spec i f i ca l l y 
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l a b e l e d o r n i t h i n e p r e c u r s o r s , a s w e l l a s some s p e c i f i c a l l y l a b e l e d 
c i t r u l l i n e p r e c u r s o r s s h o u l d b e s t u d i e d i n o r d e r t o c l a r i f y t h e p a t h w a y 
o f i n c o r p o r a t i o n i n t o v i o m y c i n o f t h e s e c o m p o u n d s . A l s o o f i n t e r e s t 
14 
w o u l d b e a n a t t e m p t t o i n c o r p o r a t e C - l a b e l e d c a p r e o m y c i d i n e i n t o 
v i o m y c i n i n o r d e r t o d e t e r m i n e w h e t h e r t h i s m a t e r i a l i s i n c o r p o r a t e d 
i n t o t h e p r e - v i o m y c i d i n e u n i t i n v i o m y c i n . 
14 
R e s e a r c h t o p i c s o f f u r t h e r i n t e r e s t m i g h t i n c l u d e a C - l a b e l m g 
s t u d y o f p e r h y d r o v i o m y c i n . S e v e r a l o f t h e b i o s y n t h e t i c e x p e r i m e n t s 
a l r e a d y c o m p l e t e d s h o u l d b e r e p e a t e d , a n d t h e v i o m y c i n p r o d u c e d s h o u l d 
b e c a t a l y t i c a l l y h y d r o g e n a t e d . H y d r o l y s i s a n d s e p a r a t i o n o f t h e 
h y d r o l y s i s c o m p o n e n t s s h o u l d r e v e a l i n f o r m a t i o n a b o u t t h e n a t u r e o f 
t h e p r e - a l a n i n e u n i t , t h e p r e - v i o m y c i d i n e u n i t , a n d t h e s o u r c e o f t h e 
c a r b o n d i o x i d e r e l e a s e d d u r i n g a c i d h y d r o l y s i s . 
APPENDIX 
SOURCES OF PRECURSORS AND PRODUCTION DATA 
FOR VIOMYCIN BIOSYNTHESIS 
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Sources of Precursors for Viomycin Biosynthesis 
Run 
No. Precursor Source 
14 
15 DL-Argmine-amidine- C 
16 Z?L-Ornithine-l- l i +C 
14 
17 Z?L-Arginine-1- C 
18 Z?-Glucose-U-14C 
14. 
19 L-a,3-Diaminopropionic-U- C Acid 
20 L-3-Lysine- l i + C 
( label ing pattern undetermined) 
14 
21 L-Viomycidine- C 
( label ing pattern undetermined) 
22 L-Lys ine - 1 5 N 
23 L-Ser ine - 1 5 N 
24 3,3-Dideuterioserine 
New England Nuclear Corp., 
Boston, Mass. 
New England Nuclear Corp., 
Boston, Mass. 
Schwarz Bioresearch I n c . , 
Orangeburg, N. Y. 
New England Nuclear Corp., 
Boston, Mass. 
Derived from Run No. 18 
Derived from Run No. 18 
Derived from Run No. 18 
Schwarz Bioresearch I n c . , 
Orangeburg, N. Y. 
Schwarz Bioresearch I n c . , 
Orangeburg, N. Y. 
Gift from Dr. C. C. 
Sweeley, Michigan State 
University 
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Production Data for Viomycin Biosynthesis 
1. 2. CO
 5. 6 . b 
Run 
No. Precursor 
Precursor 
Added 
Precursor 
Specific 
A c t i v i t y 
(dpm/ 
umole) 
Viomycin 
Produced 
(mg) 
Carrier 
Added 
(mg) 
Viomy­
cin 
Total 
(mg) 
15 DL-Arginine-
amidine- 1 1 +C 
4.93X108 dpm 6.17xl0 6 323 0.0 323 
16 DL-Ornithine-
l - l l + C 
o 
6.86x10 dpm 2.79xl0
6 247 0.0 247 
17 DL-Arginine-
l - l l + C 
7.06X108 dpm 2.53xl0 7 213 0.0 213 
18 D-Glucose-
U- l l + c 
2.16xl0 1 0dpm 
7* 
9.73x10 959 0.0 959 
19 L-a , 8-Diamino-
propionic-U- l l + C Acid 
2.09xl0 7 dpm 1.54xl0 4 165 0.0 165 
20 14 L-8-Lysine- c 
( label ing pattern 
undetermined) 
1.43xl0 7 dpm 1.19X104 225 0.0 225 
21 14 L-Viomycidine- C 
( label ing pattern 
undetermined) 
6.92xl0 6 dpm 1.24X104 307 0.0 307 
22 L-Lysine- 1 5N*HC1 0.296 mmole - 108 0.0 108 
23 L-Ser ine - 1 5 N 0.438 mmole - 213 0.0 213 
24 3,3-Dideuterioserine 0.762 mmole - 187 0.0 187 
"Includes to ta l glucose in growth medium. 
Column 4 based on preliminary assay prior to addition of car r ie r . 
Column 6 based on effluent from preparative IRC-50 column. 
97 
Production Data for Viomycin Biosynthesis 
(Continued) 
7 . ° 
C
O
 9. 10. 11. 
Run Number 
Pure 
Viomycin 
Recovered 
(mg) 
Per Cent 
Viomycin 
Recovered 
( 7 . / 6 . ) 
Viomycin 
Recovered 
Actual 
Weight 
(mg) 
Viomy­
cin 
Per Cent 
Purity 
( 7 . / 9 . ) 
Viomycin 
Total 
dpm 
Isolated 
15 181 
1 
56.1 204 88.8 1.49X107 
16 172 69.5 220 78.0 1.10X107 
17 " 152 1 71.5 171 89.0 1.18X107 
18 870 91.7 1065 81.7 1.55X108 
19 147 89.1 188 78.2 6.97xl0 5 
20 205 91.2 260 78.9 1.07X106 
21 256 83.5 321 79.8 7.58x10^ 
22 71 65.7 88 80.8 -
23 142 66.7 191 74.3 -
14 114 61.0 173 66.0 -
Column 7 based on spectrophotometric assay of f ina l product. 
Production Data for Viomycin Biosynthesis 
(Continued) 
1 2 . 1 3 . 1 4 . 
Run 
Number 
Viomycin 
Total dpm 
Produced 
( 1 1 . / 8 . ) 
Per Cent 
Incor­
poration 
( 1 2 . / 2 . ) 
Viomycin 
Specific 
A c t i v i t y 
(dpm/ 
umole) 
15 2 . 65X10 7 5 . 4 0 6 . 2 1 X 1 0 4 
16 1 . 59X10 7 2 . 3 2 4.85X10 4" 
17 1 . 6 5 X 1 0 7 2 . 3 4 5 . 8 5 x 1 0 ^ 
18 1 . 69X10 8 0 . 7 8 1 . 35X10 5 
19 7 . 82X10 5 3 . 7 4 3 . 5 7 x l 0 3 
20 1 . 17X10 6 8 . 1 5 3 . 92X10 3 
2 1 9.08xio 4 1 . 3 1 2 . 2 3 x l 0 2 
22 3 . 5 4
d 
23 - 2 . 2 6
d 
-
24 - 1 . 3 8 d -
Values based on previous experiments 
using l t + C-labeled precursors. 
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